Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16798783 | 1.00 | AKR1B1 (0.39) | AKR1B1 | |
| Alcohol SCHEMBL22806740 | 0.93 | AKR1B1 (0.35) | AKR1B1 | |
| Furan SCHEMBL28236688 | 0.83 | MAPK1 (0.31) | — | |
| SCHEMBL31249824 | 0.79 | AKR1B1 (0.31) | AKR1B1 | |
| Glucuronic Acid SCHEMBL28161769 | 0.78 | PDE4A (0.40) | — | |
| SCHEMBL183808 | 0.74 | AKR1B1 (0.36) | AKR1B1 | |
| SCHEMBL8049169 | 0.74 | AKR1B1 (0.36) | AKR1B1 | |
| SCHEMBL27733742 | 0.74 | AKR1B1 (0.36) | AKR1B1 | |
| SCHEMBL183819 | 0.70 | AKR1B1 (0.39) | AKR1B1 | |
| SCHEMBL4961423 | 0.70 | AKR1B1 (0.33) | AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 608 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250243525-A1 | BIOCATALYTIC MANUFACTURE OF SUGAR NUCLEOTIDES | ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) | 2025-07-31 | — | — | US | claimed |
| CN-119768515-A | Biocatalytic manufacture of sugar nucleotides | 齐姆特罗尼克斯催化系统股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-118994280-A | Isoflavone glycoside compound with osteoporosis resisting effect, and its extraction method and application | 湖北大学 | 2024-11-22 | — | — | CN | claimed |
| US-20240000068-A1 | Compositions and Methods for Protecting Plant Roots and Enhancing Plant Growth | MIDWESTERN BIOAG HOLDINGS, LLC | 2024-01-04 | — | — | US | claimed |
| CN-117062914-A | Methods and compositions | 植物生物科学有限公司 | 2023-11-14 | — | — | CN | claimed |
| EP-4267750-A2 | METHODS AND ENZYMES FOR PRODUCING QUILLAIC ACID DERIVATIVES | Plant Bioscience Limited (GB) | 2023-11-01 | — | — | EP | claimed |
| WO-2023192978-A2 | COMPOSITIONS AND METHODS FOR PROTECTING PLANT ROOTS AND ENHANCING PLANT GROWTH | Midwest BioAg Holdings, LLC (US) | 2023-10-05 | — | — | WO | claimed |
| US-20230309553-A1 | Compositions and Methods for Protecting Plant Roots and Enhancing Plant Growth | MIDWESTERN BIOAG HOLDINGS, LLC | 2023-10-05 | — | — | US | claimed |
| WO-2022136563-A2 | METHODS AND COMPOSITIONS | PLANT BIOSCIENCE LIMITED (GB) | 2022-06-30 | — | — | WO | claimed |
| CN-107205403-B | Use of pectin or pectin-related saccharides to increase the efficacy of plant growth-promoting rhizobacteria (PGPR) strains to promote growth and health in plants and animals | 奥本大学 | 2021-01-08 | — | — | CN | claimed |
| EP-3200590-B1 | USE OF PECTIN OR PECTIN-RELATED SACCHARIDES TO ENHANCE EFFICACY OF PLANT GROWTH-PROMOTING RHIZOBACTERIA (PGPR) STRAINS FOR PROMOTING GROWTH AND HEALTH IN PLANTS | UNIV AUBURN (US) | 2020-09-02 | — | — | EP | claimed |
| EP-3200590-A1 | USE OF PECTIN OR PECTIN-RELATED SACCHARIDES TO ENHANCE EFFICACY OF PLANT GROWTH-PROMOTING RHIZOBACTERIA (PGPR) STRAINS FOR PROMOTING GROWTH AND HEALTH IN PLANTS AND ANIMALS | Auburn University (US) | 2017-08-09 | — | — | EP | claimed |
| WO-2016054222-A1 | USE OF PECTIN OR PECTIN-RELATED SACCHARIDES TO ENHANCE EFFICACY OF PLANT GROWTH-PROMOTING RHIZOBACTERIA (PGPR) STRAINS FOR PROMOTING GROWTH AND HEALTH IN PLANTS AND ANIMALS | AUBURN UNIVERSITY (US) | 2016-04-07 | — | — | WO | claimed |
| US-20110172102-A1 | USE OF OLIGOAPIOGALACTURONANS AND THEIR DERIVATIVES TO SIMULATE DEFENCE AND RESISTANCE REACTIONS IN PLANTS AGAINST BIOTIC AND ABIOTIC STRESS SOURCES | ALGIE PLUS (FR) | 2011-07-14 | — | — | US | claimed |
| EP-2317848-A2 | USE OF APIOGALACTURONANES FOR STIMULATING THE REACTIONS OF DEFENCE AND RESISTANCE TO BIOTIC AND ABIOTIC STRESS IN PLANTS | Algie Plus (FR) | 2011-05-11 | — | — | EP | claimed |
| US-20110020226-A1 | PARTICLE STRUCTURES COMPRISING STEROLS AND SAPONINS | NORDIC VACCINE TECHNOLOGY A/S | 2011-01-27 | — | — | US | claimed |
| WO-2010017956-A2 | USE OF OLIGO-APIOGALACTURONANS AND THE DERIVATIVES THEREOF FOR STIMULATING DEFENCE AND RESISTANCE REACTIONS OF PLANTS AGAINST BIOTIC AND ABIOTIC STRESSES | ALGIE PLUS (FR) | 2010-02-18 | — | — | WO | claimed |
| US-6994966-B2 | Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof | GLYCOMINDS LTD. (IL) | 2006-02-07 | — | — | US | claimed |
| WO-2001079241-A1 | GLYCOSIDE ESTERS, THE PRODUCTION AND THE USE THEREOF IN COSMETICS, PHARMACEUTICAL PRODUCTS AND FOODSTUFF OR ANIMAL FEED | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-10-25 | — | — | WO | claimed |
| CN-120330281-B | Highland barley flavonoid compound glycosyltransferase gene and application thereof | INSTITUTE OF AGRICULTURE, TIBET AUTONOMOUS REGION ACADEMY OF AGRICULTURE AND ANIMAL HUSBANDRY (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-122036826-A | Glycoside compound and preparation method and application thereof | 广西壮族自治区中国科学院广西植物研究所 | 2026-05-15 | — | — | CN | disclosed |
| WO-2026098615-A1 | COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF IN PREPARATION OF DRUGS FOR TREATING CARDIOVASCULAR AND CEREBROVASCULAR DISEASES | 上海东西智荟生物医药有限公司 | 2026-05-15 | — | — | WO | disclosed |
| WO-2026087695-A1 | TREATMENT FOR METABOLIC DISORDER | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026087680-A1 | TREATMENT FOR CARDIOVASCULAR DISEASE | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026087679-A1 | TREATMENT FOR DISORDERS OF THE KIDNEY OR SPLEEN | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026087678-A1 | TREATMENT FOR RENAL DISORDERS | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | disclosed |
| EP-4731257-A1 | CONJUGATES OF SAPONIN AND ANTISENSE OLIGONUCLEOTIDES FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | Sapreme Technologies B.V. (NL) | 2026-04-29 | — | — | EP | disclosed |
| EP-4731261-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | Sapreme Technologies B.V. (NL) | 2026-04-29 | — | — | EP | disclosed |
| EP-3233979-B1 | METHOD FOR PREPARING A POLYMER MATERIAL MADE FROM PLANT MATERIAL | UNIV PICARDIE (FR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4728879-A1 | MEMORY DISORDER AMELIORATING AGENT | National University Corporation Kobe University (JP) | 2026-04-22 | — | — | EP | disclosed |
| EP-4719478-A1 | IMPROVED TREATMENT REGIMENS FOR THERAPEUTIC EFFECTOR COMPONENTS THAT ACT VIA AN INTRACELLULAR MOLECULAR TARGET | Sapreme Technologies B.V. (NL) | 2026-04-08 | — | — | EP | disclosed |
| US-20260077055-A1 | COMPOSITIONS OF POLYPLEXES AND SAPONINS | SAPREME TECH BV (NL) | 2026-03-19 | — | — | US | disclosed |
| US-20260076992-A1 | COMPOSITIONS AND METHODS FOR TREATING VAGINAL ATROPHY | AKANDE JANET MUBO (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4702118-A1 | A LIQUID LAUNDRY TREATMENT COMPOSITION | Unilever IP Holdings B.V. (NL) | 2026-03-04 | — | — | EP | disclosed |
| EP-4702117-A1 | A COMPOSITION FOR REDUCING MALODOUR | Unilever IP Holdings B.V. (NL) | 2026-03-04 | — | — | EP | disclosed |
| US-20260049342-A1 | METHODS AND COMPOSITIONS RELATING TO THE SYNTHESIS OF THE QS-7 MOLECULE | PLANT BIOSCIENCE LTD (GB) | 2026-02-19 | — | — | US | disclosed |
| CN-121471188-A | Apigenin betaine compound and preparation method thereof | 上海欧睿生物科技有限公司 | 2026-02-06 | — | — | CN | disclosed |
| EP-4683992-A1 | A COMPOSITION FOR REDUCING URINE MALODOUR | Unilever IP Holdings B.V. (NL) | 2026-01-28 | — | — | EP | disclosed |
| US-12523655-B2 | Leaf markers for root colonization by arbuscular mycorrhizal fungi in plants | MAX PLANCK GESELLSCHAFT (DE) | 2026-01-13 | — | — | US | disclosed |
| US-12516338-B2 | Flavone 7-o-methyltransferase gene and use for same | SUNTORY HOLDINGS LIMITED (JP) | 2026-01-06 | — | — | US | disclosed |
| US-20260000617-A1 | ORAL BIOLOGIC MACROMOLECULE DELIVERY SYSTEM | NUTRITION & BIOSCIENCES USA 1 LLC (US) | 2026-01-01 | — | — | US | disclosed |
| EP-3679924-B1 | FORMULATION COMPRISING PARTICLES | WOERWAG PHARMA GMBH & CO KG (DE) | 2025-12-17 | — | — | EP | disclosed |
| EP-4658802-A1 | PROCESS FOR MAKING DRIMANE ALDEHYDES | Firmenich SA (CH) | 2025-12-10 | — | — | EP | disclosed |
| US-20250360087-A1 | COMPOSITIONS COMPRISING LIPID DROPLETS ENCAPSULATED WITHIN POLYSACCHARIDE WALLS AND USES THEREOF | UNIV SOUTH AUSTRALIA (AU) | 2025-11-27 | — | — | US | disclosed |
| EP-3310817-B1 | PROCESS FOR EXTRACTION OF PECTIN | INT N&H DENMARK APS (DK) | 2025-11-26 | — | — | EP | disclosed |
| EP-3319457-B1 | METHOD FOR MODIFYING THE FEED INTAKE PATERN | NUTRITION SCIENCES NV (BE) | 2025-11-19 | — | — | EP | disclosed |
| US-12465571-B2 | Solid dosage form | University of Lancashire (GB) | 2025-11-11 | — | — | US | disclosed |
| EP-4640692-A2 | SEMICARBAZONE-BASED SAPONIN CONJUGATE | Sapreme Technologies B.V. (NL) | 2025-10-29 | — | — | EP | disclosed |
| EP-4635515-A2 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | Sapreme Technologies B.V. (NL) | 2025-10-22 | — | — | EP | disclosed |
| EP-4635501-A2 | SAPONIN DERIVATIVES WITH IMPROVED THERAPEUTIC WINDOW | Sapreme Technologies B.V. (NL) | 2025-10-22 | — | — | EP | disclosed |
| EP-4631524-A2 | COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE | Sapreme Technologies B.V. (NL) | 2025-10-15 | — | — | EP | disclosed |
| US-20250313646-A1 | GLYCOENGINEERED ANTIBODIES | AUGMENT BIOLOGICS, INC. | 2025-10-09 | — | — | US | disclosed |
| US-20250302865-A1 | LECTIN-BINDING CARBOHYDRATES FOR TREATING VIRAL INFECTIONS | Pharmalectin, Inc. | 2025-10-02 | — | — | US | disclosed |
| US-20250295800-A1 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | SAPREME TECH BV (NL) | 2025-09-25 | — | — | US | disclosed |
| EP-4619006-A1 | PREBIOTIC COMPOSITION FOR STABILIZING A HEALTHY GUT MICROBIOTA | NutriLeads B.V. (NL) | 2025-09-24 | — | — | EP | disclosed |
| EP-4003427-B1 | SAPONIN DERIVATIVES WITH IMPROVED THERAPEUTIC WINDOW | SAPREME TECH BV (NL) | 2025-09-17 | — | — | EP | disclosed |
| US-12415871-B2 | Method of producing a pectic polysaccharide isolate enriched in rhamnogalacturonan-I | NUTRILEADS B.V. (NL) | 2025-09-16 | — | — | US | disclosed |
| EP-4611730-A1 | ORAL BIOLOGIC MACROMOLECULE DELIVERY SYSTEM | Nutrition & Biosciences USA 1, LLC (US) | 2025-09-10 | — | — | EP | disclosed |
| CN-120607568-A | Eucalyptus type sesquiterpene glycoside compound in rhizoma atractylodis, and preparation method and application thereof | 黑龙江中医药大学 | 2025-09-09 | — | — | CN | disclosed |
| US-20250276005-A1 | POLYSACCHARIDES FOR IV ADMINISTRATION THAT TREAT SARS-COV-2 INFECTIONS | BIOXYTRAN, INC. | 2025-09-04 | — | — | US | disclosed |
| EP-4610278-A2 | TARGETED SAPONIN-NUCLEIC ACID CONJUGATES FOR TREATMENT OF MUSCLE WASTING DISORDERS | Sapreme Technologies B.V. (NL) | 2025-09-03 | — | — | EP | disclosed |
| US-20250273287-A1 | GLYCOSYLATION ENGINEERING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-08-28 | — | — | US | disclosed |
| EP-4210761-B1 | SEMICARBAZONE-BASED SAPONIN CONJUGATE | SAPREME TECH BV (NL) | 2025-08-20 | — | — | EP | disclosed |
| US-12385019-B2 | Buckwheat-derived C-glycosyltransferase gene and utilization thereof | SUNTORY HOLDINGS LIMITED (JP) | 2025-08-12 | — | — | US | disclosed |
| US-20250250564-A2 | COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS | SAPREME TECH BV (NL) | 2025-08-07 | — | — | US | disclosed |
| EP-4596052-A2 | THERAPEUTIC COMBINATION OF GALNAC-OLIGONUCLEOTIDE CONJUGATE AND SAPONIN, AND USES THEREOF | Sapreme Technologies B.V. (NL) | 2025-08-06 | — | — | EP | disclosed |
| EP-4452331-B1 | TARGETED SAPONIN-NUCLEIC ACID CONJUGATES FOR TREATMENT OF MUSCLE WASTING DISORDERS | SAPREME TECH BV (NL) | 2025-08-06 | — | — | EP | disclosed |
| US-20250243525-A1 | BIOCATALYTIC MANUFACTURE OF SUGAR NUCLEOTIDES | ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) | 2025-07-31 | — | — | US | disclosed |
| EP-4591938-A2 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | Sapreme Technologies B.V. (NL) | 2025-07-30 | — | — | EP | disclosed |
| US-20250228762-A1 | COSMETIC COMPOSITION COMPRISING LUTEIN AND A POLYSACCHARIDE | ALGAKTIV, S.L. (ES) | 2025-07-17 | — | — | US | disclosed |
| EP-4580682-A1 | COMPOSITIONS OF POLYPLEXES AND SAPONINS | Sapreme Technologies B.V. (NL) | 2025-07-09 | — | — | EP | disclosed |
| EP-3846901-B1 | PREBIOTIC FOR TREATING DISORDERS ASSOCIATED WITH DISTURBED COMPOSITION OR FUNCTIONALITY OF THE INTESTINAL MICROBIOME | NUTRILEADS B V (NL) | 2025-07-09 | — | — | EP | disclosed |
| US-20250212872-A1 | Compositions and Methods for Protecting Plant Roots and Enhancing Plant Growth | MIDWESTERN BIOAG HOLDINGS LLC (US) | 2025-07-03 | — | — | US | disclosed |
| US-20250207166-A1 | BIOSYNTHESIS | PLANT BIOSCIENCE LTD (GB) | 2025-06-26 | — | — | US | disclosed |
| US-20250205361-A1 | TREATMENT REGIMENS FOR THERAPEUTIC EFFECTOR COMPONENTS THAT ACT VIA AN INTRACELLULAR MOLECULAR TARGET | SAPREME TECHNOLOGIES B.V. (NL) | 2025-06-26 | — | — | US | disclosed |
| EP-4210760-B1 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | SAPREME TECH BV (NL) | 2025-06-18 | — | — | EP | disclosed |
| EP-4355369-B1 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | SAPREME TECH BV (NL) | 2025-06-18 | — | — | EP | disclosed |
| EP-4566600-A1 | AFFECTIVE DISORDER AMELIORATING AGENT | National University Corporation Kobe University (JP) | 2025-06-11 | — | — | EP | disclosed |
| EP-4171643-B1 | THERAPEUTIC COMBINATION OF GALNAC-OLIGONUCLEOTIDE CONJUGATE AND SAPONIN, AND USES THEREOF | SAPREME TECH BV (NL) | 2025-06-04 | — | — | EP | disclosed |
| EP-4560017-A1 | PLANT BIOMASS SACCHARIFYING ENZYME COMPOSITION | Kao Corporation (JP) | 2025-05-28 | — | — | EP | disclosed |
| EP-4547855-A1 | METHODS AND COMPOSITIONS RELATING TO THE SYNTHESIS OF THE QS-7 MOLECULE | Plant Bioscience Limited (GB) | 2025-05-07 | — | — | EP | disclosed |
| CN-119790158-A | Methods and compositions relating to the synthesis of QS-7 molecules | 植物生物科学有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119768515-A | Biocatalytic manufacture of sugar nucleotides | 齐姆特罗尼克斯催化系统股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| EP-4529953-A2 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | Sapreme Technologies B.V. (NL) | 2025-04-02 | — | — | EP | disclosed |
| CN-119351240-B | Saccharomyces cerevisiae engineering bacteria for producing glycosyl donor UDP-arabinose, construction method and application thereof | 山东第二医科大学 | 2025-03-25 | — | — | CN | disclosed |
| CN-119630396-A | Emotion disorder improving agent | 国立大学法人神户大学 | 2025-03-14 | — | — | CN | disclosed |
| US-20250082759-A1 | COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND TARGETED SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS | SAPREME TECHNOLOGIES B.V. (NL) | 2025-03-13 | — | — | US | disclosed |
| WO-2025052933-A1 | COMPOSITION, AND COMPOSITIONS FOR VISCOSITY ENHANCEMENT | DIC株式会社 | 2025-03-13 | — | — | WO | disclosed |
| CN-119585424-A | Plant biomass saccharifying enzyme composition | 花王株式会社 | 2025-03-07 | — | — | CN | disclosed |
| CN-119546753-A | Saponin biosynthetic enzymes | 植物生物科学有限公司 | 2025-02-28 | — | — | CN | disclosed |
| EP-4511401-A2 | GLYCOENGINEERED ANTIBODIES | Augment Biologics, Inc. (US) | 2025-02-26 | — | — | EP | disclosed |
| US-20250057971-A1 | TARGETED SAPONIN-NUCLEIC ACID CONJUGATES FOR TREATMENT OF MUSCLE WASTING DISORDERS | SAPREME TECHNOLOGIES B.V. (NL) | 2025-02-20 | — | — | US | disclosed |
| US-20250051770-A1 | COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS | SAPREME TECH BV (NL) | 2025-02-13 | — | — | US | disclosed |
| EP-4499817-A1 | BIOSYNTHESIS | Plant Bioscience Limited (GB) | 2025-02-05 | — | — | EP | disclosed |
| US-20250031703-A1 | USE OF PECTIN OR PECTIN-RELATED SACCHARIDES TO ENHANCE EFFICACY OF PLANT GROWTH-PROMOTING RHIZOBACTERIA (PGPR) STRAINS FOR PROMOTING GROWTH AND HEALTH IN PLANTS AND ANIMALS | AUBURN UNIVERSITY (US) | 2025-01-30 | — | — | US | disclosed |
| CN-119351240-A | Saccharomyces cerevisiae engineering bacteria for producing glycosyl donor UDP-arabinose, construction method and application thereof | 山东第二医科大学 | 2025-01-24 | — | — | CN | disclosed |
| EP-4493198-A1 | LECTIN-BINDING CARBOHYDRATES FOR TREATING VIRAL INFECTIONS | Pharmalectin, Inc. (US) | 2025-01-22 | — | — | EP | disclosed |
| EP-4396316-B1 | A HYGIENE COMPOSITION FOR REDUCING MALODOUR | UNILEVER IP HOLDINGS B V (NL) | 2025-01-22 | — | — | EP | disclosed |
| EP-4396315-B1 | A HYGIENE COMPOSITION FOR REDUCTION OF MALODOUR | UNILEVER IP HOLDINGS B V (NL) | 2025-01-15 | — | — | EP | disclosed |
| WO-2025005135-A1 | MEMORY DISORDER AMELIORATING AGENT | 国立大学法人神戸大学 | 2025-01-02 | — | — | WO | disclosed |
| CN-119212673-A | Cosmetic composition comprising lutein and polysaccharide | 阿尔加克蒂夫有限公司 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024261044-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | SAPREME TECHNOLOGIES B.V. (NL) | 2024-12-26 | — | — | WO | disclosed |
| WO-2024261042-A1 | CONJUGATES OF SAPONIN AND ANTISENSE OLIGONUCLEOTIDES FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | SAPREME TECHNOLOGIES B.V. (NL) | 2024-12-26 | — | — | WO | disclosed |
| US-20240408025-A1 | A FILM-FORMING COMPOSITION COMPRISING PECTIN | NUTRITION & BIOSCIENCES USA 1, LLC | 2024-12-12 | — | — | US | disclosed |
| US-20240408007-A1 | HYDROCOLLOID BLEND COMPOSITIONS FOR TOPICAL APPLICATION | NUTRITION & BIOSCIENCES USA 1 LLC (US) | 2024-12-12 | — | — | US | disclosed |
| WO-2024246051-A1 | IMPROVED TREATMENT REGIMENS FOR THERAPEUTIC EFFECTOR COMPONENTS THAT ACT VIA AN INTRACELLULAR MOLECULAR TARGET | SAPREME TECHNOLOGIES B.V. (NL) | 2024-12-05 | — | — | WO | disclosed |
| CN-118994280-A | Isoflavone glycoside compound with osteoporosis resisting effect, and its extraction method and application | 湖北大学 | 2024-11-22 | — | — | CN | disclosed |
| WO-2024223259-A1 | A SOLID LAUNDRY COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2024-10-31 | — | — | WO | disclosed |
| WO-2024223257-A1 | A COMPOSITION FOR REDUCING MALODOUR | UNILEVER IP HOLDINGS B.V. (NL) | 2024-10-31 | — | — | WO | disclosed |
| WO-2024223258-A1 | A LIQUID LAUNDRY TREATMENT COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2024-10-31 | — | — | WO | disclosed |
| EP-4452281-A1 | COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS | Sapreme Technologies B.V. (NL) | 2024-10-30 | — | — | EP | disclosed |
| EP-4452325-A1 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | Sapreme Technologies B.V. (NL) | 2024-10-30 | — | — | EP | disclosed |
| EP-4171641-B1 | CONJUGATE OF GALNAC AND SAPONIN, THERAPEUTIC COMPOSITION COMPRISING SAID CONJUGATE AND A GALNAC-OLIGONUCLEOTIDE CONJUGATE | SAPREME TECH BV (NL) | 2024-10-30 | — | — | EP | disclosed |
| EP-4452324-A1 | COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND TARGETED SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS | Sapreme Technologies B.V. (NL) | 2024-10-30 | — | — | EP | disclosed |
| EP-4452331-A1 | TARGETED SAPONIN-NUCLEIC ACID CONJUGATES FOR TREATMENT OF MUSCLE WASTING DISORDERS | Sapreme Technologies B.V. (NL) | 2024-10-30 | — | — | EP | disclosed |
| US-20240355424-A1 | CLINICAL DIAGNOSTICS USING GLYCANS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-10-24 | — | — | US | disclosed |
| CN-118772242-A | CD137 specific bicyclic peptide ligands | 拜斯科技术开发有限公司 | 2024-10-15 | — | — | CN | disclosed |
| US-20240327829-A1 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | SAPREME TECHNOLOGIES B.V. (NL) | 2024-10-03 | — | — | US | disclosed |
| EP-4438125-A2 | CONJUGATE OF GALNAC AND SAPONIN, THERAPEUTIC COMPOSITION COMPRISING SAID CONJUGATE AND A GALNAC OLIGONUCLEOTIDE CONJUGATE | Sapreme Technologies B.V. (NL) | 2024-10-02 | — | — | EP | disclosed |
| CN-118742650-A | Production of saponins in yeast | 加利福尼亚大学董事会 | 2024-10-01 | — | — | CN | disclosed |
| WO-2024193924-A1 | A COMPOSITION FOR REDUCING URINE MALODOUR | UNILEVER IP HOLDINGS B.V. (NL) | 2024-09-26 | — | — | WO | disclosed |
| US-20240307545-A1 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | SAPREME TECHNOLOGIES B.V. (NL) | 2024-09-19 | — | — | US | disclosed |
| US-12089598-B2 | Use of pectin or pectin-related saccharides to enhance efficacy of plant growth-promoting rhizobacteria (PGPR) strains for promoting growth and health in plants and animals | AUBURN UNIVERSITY (US) | 2024-09-17 | — | — | US | disclosed |
| EP-4426808-A1 | HYGIENE COMPOSITION FOR REDUCTION OF MALODOUR | Unilever IP Holdings B.V. (NL) | 2024-09-11 | — | — | EP | disclosed |
| US-20240293328-A1 | Solid Dosage Form | UNIVERSITY OF CENTRAL LANCASHIRE (GB) | 2024-09-05 | — | — | US | disclosed |
| WO-2024160757-A1 | PROCESS FOR MAKING DRIMANE ALDEHYDES | FIRMENICH SA (CH) | 2024-08-08 | — | — | WO | disclosed |
| EP-4408393-A1 | HYDROCOLLOID BLEND COMPOSITIONS FOR TOPICAL APPLICATION | Nutrition & Biosciences USA 1, LLC (US) | 2024-08-07 | — | — | EP | disclosed |
| CN-118434449-A | Compositions comprising therapeutic nucleic acids and targeted saponins for the treatment of muscle wasting disorders | 萨普雷米科技有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-118414172-A | Targeted saponin-nucleic acid conjugates for the treatment of muscle wasting disorders | 萨普雷米科技有限公司 | 2024-07-30 | — | — | CN | disclosed |
| EP-4401709-A1 | A FILM-FORMING COMPOSITION COMPRISING PECTIN | Nutrition & Biosciences USA 1, LLC (US) | 2024-07-24 | — | — | EP | disclosed |
| CN-118344425-A | Polyhydroxy pentacyclic triterpene compound and preparation method and application thereof | 华东理工大学 | 2024-07-16 | — | — | CN | disclosed |
| EP-4396316-A1 | A HYGIENE COMPOSITION FOR REDUCING MALODOUR | Unilever IP Holdings B.V. (NL) | 2024-07-10 | — | — | EP | disclosed |
| EP-4396315-A1 | A HYGIENE COMPOSITION FOR REDUCTION OF MALODOUR | Unilever IP Holdings B.V. (NL) | 2024-07-10 | — | — | EP | disclosed |
| CN-111183147-B | CD137 specific bicyclic peptide ligands | 拜斯科技术开发有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-118165050-A | Novel alcohol glycoside compound in rhizoma atractylodis, and preparation method and application thereof | 黑龙江中医药大学 | 2024-06-11 | — | — | CN | disclosed |
| CN-118176284-A | Sanitary composition for reducing odor | 联合利华知识产权控股有限公司 | 2024-06-11 | — | — | CN | disclosed |
| WO-2024105131-A1 | PREBIOTIC COMPOSITION FOR STABILIZING A HEALTHY GUT MICROBIOTA | NUTRILEADS B.V. (NL) | 2024-05-23 | — | — | WO | disclosed |
| EP-4367211-A1 | A COMPOSITION FOR REDUCING MALODOUR | Unilever IP Holdings B.V. (NL) | 2024-05-15 | — | — | EP | disclosed |
| WO-2024097926-A1 | ORAL BIOLOGIC MACROMOLECULE DELIVERY SYSTEM | NUTRITION & BIOSCIENCES USA 1, LLC (US) | 2024-05-10 | — | — | WO | disclosed |
| CN-114920796-B | Steroid saponin compound extracted from paris polyphylla, preparation and application | 中国人民解放军空军军医大学 | 2024-05-07 | — | — | CN | disclosed |
| CN-117925767-A | Application of lactobacillus plantarum M3 in improving content of secondary saponin of platycodon grandiflorum and lipid-lowering activity | 沈阳农业大学 | 2024-04-26 | — | — | CN | disclosed |
| EP-4355369-A1 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | Sapreme Technologies B.V. (NL) | 2024-04-24 | — | — | EP | disclosed |
| US-20240122961-A1 | PREBIOTIC FOR TREATING DISORDERS ASSOCIATED WITH DISTURBED COMPOSITION OR FUNCTIONALITY OF THE INTESTINAL MICROBIOME | NUTRILEADS B.V. (NL) | 2024-04-18 | — | — | US | disclosed |
| EP-3720449-B1 | COMPOSITION FOR USE IN THE PREVENTION OR TREATMENT OF SALMONELLOSIS | NUTRILEADS B V (NL) | 2024-04-17 | — | — | EP | disclosed |
| US-20240115712-A1 | SEMICARBAZONE-BASED SAPONIN CONJUGATE | SAPREME TECHNOLOGIES B.V. (NL) | 2024-04-11 | — | — | US | disclosed |
| US-20240115726-A1 | HYDRAZONE-BASED SAPONIN DERIVATIVES | SAPREME TECHNOLOGIES B.V. (NL) | 2024-04-11 | — | — | US | disclosed |
| WO-2024074377-A1 | RHAMNOGALACTURORAN I FOR USE IN THE TREATMENT OF DYSPNEA OR PERSISTENT COUGH CAUSED OR EXACERBATED BY VIRAL RESPIRATORY INFECTION IN PATIENTS SUFFERING FROM ASTHMA, COPD OR POST-VIRAL LUNG COMPLAINTS | NUTRILEADS B.V. (NL) | 2024-04-11 | — | — | WO | disclosed |
| EP-3188713-B2 | METHOD OF INDUCING SATIETY | PERORA GMBH (DE) | 2024-04-10 | — | — | EP | disclosed |
| CN-117837746-A | Food and/or feed composition for preventing and treating inflammatory diseases | 帝斯曼知识产权资产管理有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-117825302-A | Quantitative method of II-type rhamnogalacturonan and application thereof | 上海中医药大学 | 2024-04-05 | — | — | CN | disclosed |
| EP-3700350-B1 | METHOD OF PRODUCING A PECTIC POLYSACCHARIDE ISOLATE ENRICHED IN RHAMNOGALACTURONAN-I | NUTRILEADS B V (NL) | 2024-04-03 | — | — | EP | disclosed |
| EP-3700357-B1 | ENZYMATICALLY HYDROLYSED PECTIC POLYSACCHARIDES FOR TREATING OR PREVENTING INFECTIONS | NUTRILEADS B V (NL) | 2024-04-03 | — | — | EP | disclosed |
| CN-117795047-A | Sanitary composition for reducing odor | 联合利华知识产权控股有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117795046-A | Sanitary composition for reducing peculiar smell | 联合利华知识产权控股有限公司 | 2024-03-29 | — | — | CN | disclosed |
| US-20240102069-A1 | METHODS AND COMPOSITIONS | PLANT BIOSCIENCE LIMITED (GB) | 2024-03-28 | — | — | US | disclosed |
| CN-117716009-A | Composition for reducing off-flavors | 联合利华知识产权控股有限公司 | 2024-03-15 | — | — | CN | disclosed |
| WO-2024046622-A1 | COMPOSITIONS OF POLYPLEXES AND SAPONINS | SAPREME TECHNOLOGIES B.V. (NL) | 2024-03-07 | — | — | WO | disclosed |
| US-20240076299-A1 | TUBERCULATIN ANALOGS AS ANTIVIRAL AGENTS | HONG KONG BAPTIST UNIVERSITY (CN) | 2024-03-07 | — | — | US | disclosed |
| EP-4331610-A1 | POLYPLEX-SAPONIN COVALENT CONJUGATE | Sapreme Technologies B.V. (NL) | 2024-03-06 | — | — | EP | disclosed |
| EP-4331609-A1 | METHODS AND COMPOSITIONS FOR ENHANCED POLYPLEX DELIVERY | Sapreme Technologies B.V. (NL) | 2024-03-06 | — | — | EP | disclosed |
| US-20240066045-A1 | SEMICARBAZONE-BASED SAPONIN CONJUGATE | SAPREME TECHNOLOGIES B.V. (NL) | 2024-02-29 | — | — | US | disclosed |
| WO-2024029239-A1 | AFFECTIVE DISORDER AMELIORATING AGENT | 国立大学法人神戸大学 | 2024-02-08 | — | — | WO | disclosed |
| WO-2024016079-A1 | METHODS FOR TRANSFORMING POLYSACCHARIDES TO CROSS-LINKABLE POLYSACCHARIDES AND PRODUCTS THEREOF | UNIVERSITY OF OTTAWA (CA) | 2024-01-25 | — | — | WO | disclosed |
| WO-2024019128-A1 | PLANT BIOMASS SACCHARIFYING ENZYME COMPOSITION | 花王株式会社 | 2024-01-25 | — | — | WO | disclosed |
| WO-2024010609-A1 | PRISTINE GRAPHENE BASED BIOSENSOR FOR BIOMARKER DETECTION AND RELATED CORE PARTICLES, MATERIALS COMPOSITIONS METHODS AND SYSTEMS | HAWKEYE BIO, LIMITED (IE) | 2024-01-11 | — | — | WO | disclosed |
| WO-2024003514-A1 | METHODS AND COMPOSITIONS RELATING TO THE SYNTHESIS OF THE QS-7 MOLECULE | PLANT BIOSCIENCE LIMITED (GB) | 2024-01-04 | — | — | WO | disclosed |
| US-20240000068-A1 | Compositions and Methods for Protecting Plant Roots and Enhancing Plant Growth | MIDWESTERN BIOAG HOLDINGS, LLC | 2024-01-04 | — | — | US | disclosed |
| WO-2023250198-A1 | BIOCATALYTIC MANUFACTURE OF SUGAR NUCLEOTIDES | ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023235938-A1 | COMPOSITIONS COMPRISING LIPID DROPLETS ENCAPSULATED WITHIN POLYSACCHARIDE WALLS AND USES THEREOF | UNIVERSITY OF SOUTH AUSTRALIA (AU) | 2023-12-14 | — | — | WO | disclosed |
| US-20230365617-A1 | SAPONIN DERIVATIVES FOR USE IN MEDICINE | SAPREME TECHNOLOGIES B.V. (NL) | 2023-11-16 | — | — | US | disclosed |
| CN-117062914-A | Methods and compositions | 植物生物科学有限公司 | 2023-11-14 | — | — | CN | disclosed |
| US-20230357310-A1 | Saponin derivatives with improved therapeutic window | SAPREME TECHNOLOGIES B.V. (NL) | 2023-11-09 | — | — | US | disclosed |
| EP-4267630-A1 | POLYSACCHARIDES HAVING IMPROVED RADIOCONTRAST PROPERTIES | Boston Scientific Scimed, Inc. (US) | 2023-11-01 | — | — | EP | disclosed |
| EP-4267750-A2 | METHODS AND ENZYMES FOR PRODUCING QUILLAIC ACID DERIVATIVES | Plant Bioscience Limited (GB) | 2023-11-01 | — | — | EP | disclosed |
| WO-2023205659-A2 | GLYCOENGINEERED ANTIBODIES | AUGMENT BIOLOGICS, INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| WO-2023205642-A2 | GLYCOSYLATION ENGINEERING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-26 | — | — | WO | disclosed |
| EP-4263532-A1 | TUBERCULATIN ANALOGS AS ANTIVIRAL AGENTS | Hong Kong Baptist University (CN) | 2023-10-25 | — | — | EP | disclosed |
| CN-116916880-A | Cosmetic product | 株式会社资生堂 | 2023-10-20 | — | — | CN | disclosed |
| WO-2023192978-A2 | COMPOSITIONS AND METHODS FOR PROTECTING PLANT ROOTS AND ENHANCING PLANT GROWTH | Midwest BioAg Holdings, LLC (US) | 2023-10-05 | — | — | WO | disclosed |
| US-20230309553-A1 | Compositions and Methods for Protecting Plant Roots and Enhancing Plant Growth | MIDWESTERN BIOAG HOLDINGS, LLC | 2023-10-05 | — | — | US | disclosed |
| US-20230302140-A1 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | SAPREME TECHNOLOGIES B.V. (NL) | 2023-09-28 | — | — | US | disclosed |
| WO-2023180677-A1 | Biosynthesis | PLANT BIOSCIENCE LIMITED (GB) | 2023-09-28 | — | — | WO | disclosed |
| WO-2023178228-A1 | LECTIN-BINDING CARBOHYDRATES FOR TREATING VIRAL INFECTIONS | Pharmalectin, Inc. (US) | 2023-09-21 | — | — | WO | disclosed |
| US-20230293562-A1 | THERAPEUTIC COMBINATION OF GALNAC-OLIGONUCLEOTIDE CONJUGATE AND SAPONIN, AND USES THEREOF | SAPREME TECHNOLOGIES B.V. (NL) | 2023-09-21 | — | — | US | disclosed |
| US-20230293708-A1 | CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF | SAPREME TECHNOLOGIES B.V. (NL) | 2023-09-21 | — | — | US | disclosed |
| CN-116783291-A | Cellular production of glycosylation products | 因比奥斯公司 | 2023-09-19 | — | — | CN | disclosed |
| US-20230287038-A1 | PURIFIED SAPONINS AND CHROMATOGRAPHIC PROCESS FOR PURIFICATION OF SAME | ACCESS TO ADVANCED HEALTH INSTITUTE | 2023-09-14 | — | — | US | disclosed |
| EP-4240374-A1 | POLYSACCHARIDES FOR IV ADMINISTRATION THAT TREAT SARS-COV-2 INFECTIONS | Pharmalectin, Inc. (US) | 2023-09-13 | — | — | EP | disclosed |
| US-20230277612-A1 | SAPONIN DERIVATIVES FOR USE IN MEDICINE | SAPREME TECHNOLOGIES B.V. (NL) | 2023-09-07 | — | — | US | disclosed |
| US-20230277680-A1 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | SAPREME TECHNOLOGIES B.V. (NL) | 2023-09-07 | — | — | US | disclosed |
| US-20230270872-A1 | CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF | SAPREME TECHNOLOGIES B.V. (NL) | 2023-08-31 | — | — | US | disclosed |
| US-20230263897-A1 | CONJUGATE OF GALNAC AND SAPONIN, THERAPEUTIC COMPOSITION COMPRISING SAID CONJUGATE AND A GALNAC-OLIGONUCLEOTIDE CONJUGATE | SAPREME TECHNOLOGIES B.V. (NL) | 2023-08-24 | — | — | US | disclosed |
| CN-116635037-A | Mountain lotus leaf apigenin analogue as antiviral agent | 香港浸会大学 | 2023-08-22 | — | — | CN | disclosed |
| US-20230256111-A1 | COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE | SAPREME TECHNOLOGIES B.V. (NL) | 2023-08-17 | — | — | US | disclosed |
| US-11723915-B2 | Enzymatically hydrolysed pectic polysaccharides for treating or preventing infections | NUTRILEADS B.V. (NL) | 2023-08-15 | — | — | US | disclosed |
| CN-116583304-A | Polysaccharide with improved radiocontrast properties | 波士顿科学医学有限公司 | 2023-08-11 | — | — | CN | disclosed |
| US-20230248845-A1 | COMBINATION OF AN ANTIBODY-DRUG CONJUGATE AND AN ANTIBODY-SAPONIN CONJUGATE | SAPREME TECHNOLOGIES B.V. (NL) | 2023-08-10 | — | — | US | disclosed |
| US-20230248844-A1 | COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE | SAPREME TECHNOLOGIES B.V. (NL) | 2023-08-10 | — | — | US | disclosed |
| US-11718918-B2 | Method for inhibiting metal corrosion during acid cleaning or pickling | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2023-08-08 | — | — | US | disclosed |
| CN-109477078-B | Improved production of meso-galactaric acid from galacturonic acid using genetically modified fungal cells | 芬兰国家技术研究中心股份公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-113854538-B | Preparation method of instant emulsion for improving emulsion interface stability | 南京农业大学 | 2023-07-21 | — | — | CN | disclosed |
| EP-4210760-A1 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | Sapreme Technologies B.V. (NL) | 2023-07-19 | — | — | EP | disclosed |
| EP-4210761-A1 | SEMICARBAZONE-BASED SAPONIN CONJUGATE | Sapreme Technologies B.V. (NL) | 2023-07-19 | — | — | EP | disclosed |
| CN-116437965-A | Conjugates of saponins, oligonucleotides and GALNAC | 萨普雷米科技有限公司 | 2023-07-14 | — | — | CN | disclosed |
| US-20230220357-A1 | BUCKWHEAT-DERIVED C-GLYCOSYLTRANSFERASE GENE AND UTILIZATION THEREOF | SUNTORY HOLDINGS LIMITED (JP) | 2023-07-13 | — | — | US | disclosed |
| US-20230212326-A1 | PECTIN EXTRACTION PROCESS | INTERNATIONAL N&H DENMARK APS (DK) | 2023-07-06 | — | — | US | disclosed |
| CN-116390932-A | Saponin derivative for use in medicine | 萨普雷米科技有限公司 | 2023-07-04 | — | — | CN | disclosed |
| WO-2023121445-A1 | COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS | SAPREME TECHNOLOGIES B.V. (NL) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023121444-A1 | COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND TARGETED SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS | SAPREME TECHNOLOGIES B.V. (NL) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023121446-A1 | TARGETED SAPONIN-NUCLEIC ACID CONJUGATES FOR TREATMENT OF MUSCLE WASTING DISORDERS | SAPREME TECHNOLOGIES B.V. (NL) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023121447-A1 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | SAPREME TECHNOLOGIES B.V. (NL) | 2023-06-29 | — | — | WO | disclosed |
| CN-116322782-A | Conjugate of single domain antibody, saponin and effector molecule, pharmaceutical composition comprising same, therapeutic use of said pharmaceutical composition | 萨普雷米科技有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116322783-A | Conjugate of single domain antibody, saponin and effector molecule, pharmaceutical composition comprising same, therapeutic use of said pharmaceutical composition | 萨普雷米科技有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116261469-A | Combinations comprising an ADC or AOC containing a VHH and a saponin or ligand-saponin conjugate | 萨普雷米科技有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-116249553-A | Combination of antibody-drug conjugate and antibody-saponin conjugate | 萨普雷米科技有限公司 | 2023-06-09 | — | — | CN | disclosed |
| US-20230173142-A1 | BALLISTIC DELIVERY TO MULTILAYERED TISSUES AND RELATED PARTICLES, COMPOSITIONS, METHODS AND SYSTEMS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2023-06-08 | — | — | US | disclosed |
| CN-116234582-A | Conjugates of GalNAc and saponin, therapeutic compositions comprising said conjugates and GalNAc-oligonucleotide conjugates | 萨普雷米科技有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-116194148-A | Therapeutic combinations of GalNAc-oligonucleotide conjugates and saponins and uses thereof | 萨普雷米科技有限公司 | 2023-05-30 | — | — | CN | disclosed |
| WO-2023078894-A1 | HYGIENE COMPOSITION FOR REDUCTION OF MALODOUR | UNILEVER IP HOLDINGS B.V. (NL) | 2023-05-11 | — | — | WO | disclosed |
| EP-4171646-A1 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | Sapreme Technologies B.V. (NL) | 2023-05-03 | — | — | EP | disclosed |
| EP-4171647-A2 | COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE | Sapreme Technologies B.V. (NL) | 2023-05-03 | — | — | EP | disclosed |
| EP-4171639-A2 | SAPONIN DERIVATIVES FOR USE IN MEDICINE | Sapreme Technologies B.V. (NL) | 2023-05-03 | — | — | EP | disclosed |
| EP-4171640-A1 | CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF | Sapreme Technologies B.V. (NL) | 2023-05-03 | — | — | EP | disclosed |
| EP-4171645-A2 | HYDRAZONE-BASED SAPONIN DERIVATIVES | Sapreme Technologies B.V. (NL) | 2023-05-03 | — | — | EP | disclosed |
| EP-4171642-A1 | COMBINATION OF AN ANTIBODY-DRUG CONJUGATE AND AN ANTIBODY-SAPONIN CONJUGATE | Sapreme Technologies B.V. (NL) | 2023-05-03 | — | — | EP | disclosed |
| EP-4171643-A1 | THERAPEUTIC COMBINATION OF GALNAC-OLIGONUCLEOTIDE CONJUGATE AND SAPONIN, AND USES THEREOF | Sapreme Technologies B.V. (NL) | 2023-05-03 | — | — | EP | disclosed |
| EP-4171641-A1 | CONJUGATE OF GALNAC AND SAPONIN, THERAPEUTIC COMPOSITION COMPRISING SAID CONJUGATE AND A GALNAC-OLIGONUCLEOTIDE CONJUGATE | Sapreme Technologies B.V. (NL) | 2023-05-03 | — | — | EP | disclosed |
| EP-4171644-A2 | SAPONIN DERIVATIVES FOR USE IN MEDICINE | Sapreme Technologies B.V. (NL) | 2023-05-03 | — | — | EP | disclosed |
| WO-2023052599-A1 | HYDROCOLLOID BLEND COMPOSITIONS FOR TOPICAL APPLICATION | NUTRITION & BIOSCIENCES USA 1, LLC (US) | 2023-04-06 | — | — | WO | disclosed |
| CN-115844744-A | Cosmetic preparation | 株式会社资生堂 | 2023-03-28 | — | — | CN | disclosed |
| EP-4149284-A1 | PECTIN EXTRACTION PROCESS | DuPont Nutrition Biosciences ApS (DK) | 2023-03-22 | — | — | EP | disclosed |
| WO-2023036581-A1 | A FILM-FORMING COMPOSITION COMPRISING PECTIN | NUTRITION & BIOSCIENCES USA 1, LLC (US) | 2023-03-16 | — | — | WO | disclosed |
| WO-2023038517-A1 | SEMICARBAZONE-BASED SAPONIN CONJUGATE | SAPREME TECHNOLOGIES B.V. (NL) | 2023-03-16 | — | — | WO | disclosed |
| US-20230078244-A1 | FAT FREE, NON-DAIRY SOFT SERVE COMPOSITIONS | THE COCA-COLA COMPANY | 2023-03-16 | — | — | US | disclosed |
| WO-2023031007-A1 | A HYGIENE COMPOSITION FOR REDUCING MALODOUR | UNILEVER IP HOLDINGS B.V. (NL) | 2023-03-09 | — | — | WO | disclosed |
| WO-2023031005-A1 | A HYGIENE COMPOSITION FOR REDUCTION OF MALODOUR | UNILEVER IP HOLDINGS B.V. (NL) | 2023-03-09 | — | — | WO | disclosed |
| WO-2023034383-A2 | CLINICAL DIAGNOSTICS USING GLYCANS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-03-09 | — | — | WO | disclosed |
| US-20230058072-A1 | COSMETIC COMPOSITION | CREASEARCH BV (BE) | 2023-02-23 | — | — | US | disclosed |
| EP-4126060-A1 | COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE | Sapreme Technologies B.V. (NL) | 2023-02-08 | — | — | EP | disclosed |
| CN-108348592-B | Vaccine | 葛兰素史密丝克莱恩生物有限公司 | 2023-02-03 | — | — | CN | disclosed |
| EP-4117730-A1 | CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF | Sapreme Technologies B.V. (NL) | 2023-01-18 | — | — | EP | disclosed |
| EP-4117731-A1 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | Sapreme Technologies B.V. (NL) | 2023-01-18 | — | — | EP | disclosed |
| WO-2023280592-A1 | A COMPOSITION FOR REDUCING MALODOUR | UNILEVER IP HOLDINGS B.V. (NL) | 2023-01-12 | — | — | WO | disclosed |
| EP-4114190-A1 | FAT FREE, NON-DAIRY SOFT SERVE COMPOSITIONS | The Coca-Cola Company (US) | 2023-01-11 | — | — | EP | disclosed |
| CN-115581671-A | Formulations comprising particles | 佩罗拉股份有限公司 | 2023-01-10 | — | — | CN | disclosed |
| CN-115569117-A | Method of inducing satiety | 佩罗拉股份有限公司 | 2023-01-06 | — | — | CN | disclosed |
| WO-2022265493-A1 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | SAPREME TECHNOLOGIES B.V. (NL) | 2022-12-22 | — | — | WO | disclosed |
| CN-115484828-A | Fat-free non-dairy cream composition | 可口可乐公司 | 2022-12-16 | — | — | CN | disclosed |
| CN-111574579-B | Preparation method of dammarane type saponin and application of dammarane type saponin in preparation of hypoglycemic and anti-inflammatory drugs and health-care products | 广西师范大学 | 2022-12-13 | — | — | CN | disclosed |
| US-11524025-B2 | Composition for use in the prevention or treatment of salmonellosis | NUTRILEADS B.V. (NL) | 2022-12-13 | — | — | US | disclosed |
| EP-4096621-A1 | COSMETIC COMPOSITION | CreaSearch BV (BE) | 2022-12-07 | — | — | EP | disclosed |
| US-11504330-B2 | Formulation comprising particles containing a water-swellable or water-soluble polymeric component and a lipid component | PERORA GMBH (DE) | 2022-11-22 | — | — | US | disclosed |
| CN-112924426-B | Fluorescent array sensor based on perylene diimide derivatives and construction method and application thereof | 中国药科大学 | 2022-11-08 | — | — | CN | disclosed |
| US-20220331255-A1 | Solid Dosage Form | UNIVERSITY OF CENTRAL LANCASHIRE (GB) | 2022-10-20 | — | — | US | disclosed |
| WO-2022210148-A1 | COSMETIC PREPARATION | 株式会社 資生堂 | 2022-10-06 | — | — | WO | disclosed |
| US-20220316073-A1 | METHOD FOR INHIBITING METAL CORROSION DURING ACID CLEANING OR PICKLING | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-10-06 | — | — | US | disclosed |
| EP-4067388-A1 | PROCESS FOR EXTRACTION OF PECTIN CONTAINING PRODUCT AND CITRUS FIBER | DuPont Nutrition Biosciences ApS (DK) | 2022-10-05 | — | — | EP | disclosed |
| CN-114920796-A | Steroid saponin compound extracted from Paris polyphylla with stalk and its preparation and use | 中国人民解放军空军军医大学 | 2022-08-19 | — | — | CN | disclosed |
| US-20220249674-A1 | BIOACTIVE SAPONIN LINKED TO A FUNCTIONAL MOIETY | SAPREME TECHNOLOGIES B.V. (NL) | 2022-08-11 | — | — | US | disclosed |
| EP-4039804-A1 | BUCKWHEAT-DERIVED C-GLYCOSYLTRANSFERASE GENE AND UTILIZATION THEREOF | Suntory Holdings Limited (JP) | 2022-08-10 | — | — | EP | disclosed |
| EP-3083703-B1 | PROCESS FOR EXTRACTION OF CALCIUM SENSITIVE PECTIN | DUPONT NUTRITION BIOSCI APS (DK) | 2022-08-10 | — | — | EP | disclosed |
| US-11408079-B2 | Corrosion inhibitor composition and methods of inhibiting corrosion during acid pickling | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-08-09 | — | — | US | disclosed |
| WO-2022164316-A1 | SEMICARBAZONE-BASED SAPONIN CONJUGATE | SAPREME TECHNOLOGIES B.V. (NL) | 2022-08-04 | — | — | WO | disclosed |
| WO-2022159614-A1 | STABLE ORGANIC CANNABINOID OIL BLEND FORMULATIONS | THERABODY, INC. (US) | 2022-07-28 | — | — | WO | disclosed |
| WO-2022146749-A1 | POLYSACCHARIDES HAVING IMPROVED RADIOCONTRAST PROPERTIES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2022-07-07 | — | — | WO | disclosed |
| CN-113025674-B | Preparation method and application of lemon pectin enzymolysis product with anti-tumor activity | 遵义医科大学 | 2022-07-05 | — | — | CN | disclosed |
| US-20220204655-A1 | POLYSACCHARIDES HAVING IMPROVED RADIOCONTRAST PROPERTIES | BOSTON SCIENTIFIC SCIMED, INC. | 2022-06-30 | — | — | US | disclosed |
| US-20220202850-A1 | METHOD OF INDUCING SATIETY | PERORA GMBH (DE) | 2022-06-30 | — | — | US | disclosed |
| WO-2022135136-A1 | TUBERCULATIN ANALOGS AS ANTIVIRAL AGENTS | HONG KONG BAPTIST UNIVERSITY (CN) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022136563-A2 | METHODS AND COMPOSITIONS | PLANT BIOSCIENCE LIMITED (GB) | 2022-06-30 | — | — | WO | disclosed |
| CN-114641573-A | Transferases | 植物生物科学有限公司 | 2022-06-17 | — | — | CN | disclosed |
| US-20220186240-A1 | FLAVONE 7-O-METHYLTRANSFERASE GENE AND USE FOR SAME | SUNTORY HOLDINGS LIMITED (JP) | 2022-06-16 | — | — | US | disclosed |
| EP-4003427-A1 | SAPONIN DERIVATIVES WITH IMPROVED THERAPEUTIC WINDOW | SAPREME TECHNOLOGIES B.V. (NL) | 2022-06-01 | — | — | EP | disclosed |
| EP-4003425-A2 | BIOACTIVE SAPONIN LINKED TO A FUNCTIONAL MOIETY | SAPREME TECHNOLOGIES B.V. (NL) | 2022-06-01 | — | — | EP | disclosed |
| CN-113321696-B | Preparation method of cardiac glycoside and application of cardiac glycoside in preparation of antitumor drugs | 广西师范大学 | 2022-05-31 | — | — | CN | disclosed |
| US-11332723-B2 | Engineered microorganisms for production of commodity chemicals and cellular biomass | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-05-17 | — | — | US | disclosed |
| WO-2022099061-A1 | POLYSACCHARIDES FOR IV ADMINISTRATION THAT TREAT SARS-COV-2 INFECTIONS | BIOXYTRAN, INC. (US) | 2022-05-12 | — | — | WO | disclosed |
| CN-114450404-A | C-glycosidase gene derived from buckwheat and use thereof | 三得利控股株式会社 | 2022-05-06 | — | — | CN | disclosed |
| US-11311570-B2 | Method of inducing satiety | PERORA GMBH (DE) | 2022-04-26 | — | — | US | disclosed |
| CN-110922444-B | Panaxadiol type triterpenoid saponin with anti-inflammatory activity | 天津中医药大学 | 2022-04-15 | — | — | CN | disclosed |
| CN-114315951-A | Steroid saponin compound extracted from Paris polyphylla with stalk, and its preparation method and application | 中国人民解放军空军军医大学 | 2022-04-12 | — | — | CN | disclosed |
| US-11291216-B2 | Base emulsion for the preparation of icings, fillings and toppings | BRILL, INC. (US) | 2022-04-05 | — | — | US | disclosed |
| US-20220095628-A1 | USE OF PECTIN OR PECTIN-RELATED SACCHARIDES TO ENHANCE EFFICACY OF PLANT GROWTH-PROMOTING RHIZOBACTERIA (PGPR) STRAINS FOR PROMOTING GROWTH AND HEALTH IN PLANTS AND ANIMALS | AUBURN UNIVERSITY (US) | 2022-03-31 | — | — | US | disclosed |
| CN-114222750-A | Saponin derivatives for improving therapeutic window | 萨普雷米科技有限公司 | 2022-03-22 | — | — | CN | disclosed |
| WO-2022055352-A1 | SEMICARBAZONE-BASED SAPONIN CONJUGATE | SAPREME TECHNOLOGIES B.V. (NL) | 2022-03-17 | — | — | WO | disclosed |
| WO-2022055351-A1 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | SAPREME TECHNOLOGIES B.V. (NL) | 2022-03-17 | — | — | WO | disclosed |
| EP-3292859-B1 | HIGH DOSE, CHEWABLE VITAMIN FORMULATIONS | IPSICO UG (DE) | 2022-02-23 | — | — | EP | disclosed |
| US-20220015943-A1 | BALLISTIC DELIVERY AND RELATED PARTICLES, COMPOSITIONS, METHODS AND SYSTEMS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2022-01-20 | — | — | US | disclosed |
| EP-3939598-A1 | PECTIN COMPOSITIONS FOR PREVENTING AND TREATING INFLAMMATORY DISEASES | Nutrition Sciences N.V. (BE) | 2022-01-19 | — | — | EP | disclosed |
| WO-2021228963-A1 | PECTIN EXTRACTION PROCESS | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2021-11-18 | — | — | WO | disclosed |
| EP-3895710-A1 | FOOD AND/OR FEED COMPOSITIONS TO MANAGE IMMUNE HOMEOSTASIS | DSM IP Assets B.V. (NL) | 2021-10-20 | — | — | EP | disclosed |
| WO-2021178532-A1 | FAT FREE, NON-DAIRY SOFT SERVE COMPOSITIONS | THE COCA-COLA COMPANY (US) | 2021-09-10 | — | — | WO | disclosed |
| CN-113321696-A | Preparation method of cardiac glycoside and application of cardiac glycoside in preparation of antitumor drugs | 广西师范大学 | 2021-08-31 | — | — | CN | disclosed |
| WO-2021140228-A1 | COSMETIC COMPOSITION | CREASEARCH BV (BE) | 2021-07-15 | — | — | WO | disclosed |
| EP-3848019-A1 | COSMETIC COMPOSION COMPRISING A SAPONIN AND A PROBIOTIC COMPONENT | CreaSearch BV (BE) | 2021-07-14 | — | — | EP | disclosed |
| EP-3846901-A1 | PREBIOTIC FOR TREATING DISORDERS ASSOCIATED WITH DISTURBED COMPOSITION OR FUNCTIONALITY OF THE INTESTINAL MICROBIOME | NutriLeads B.V. (NL) | 2021-07-14 | — | — | EP | disclosed |
| US-11040060-B2 | Food compositions for managing body weight | DSM IP ASSETS B.V. (NL) | 2021-06-22 | — | — | US | disclosed |
| US-20210177886-A1 | PREBIOTIC FOR TREATING DISORDERS ASSOCIATED WITH DISTURBED COMPOSITION OR FUNCTIONALITY OF THE INTESTINAL MICROBIOME | NUTRILEADS B.V. (NL) | 2021-06-17 | — | — | US | disclosed |
| US-11020423-B2 | Food and/or feed compositions for preventing and treating inflammatory diseases | DSM IP ASSETS B.V. (NL) | 2021-06-01 | — | — | US | disclosed |
| CN-112739417-A | Prebiotics for the treatment of disorders associated with disturbed composition or function of the gut microbiome | 纽崔利兹有限公司 | 2021-04-30 | — | — | CN | disclosed |
| US-10982239-B2 | Method for producing meso-galactaric acid by contacting a fungal cell with a biomaterial having galacturonic acid | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2021-04-20 | — | — | US | disclosed |
| US-20210084948-A1 | SAVOURY CONCENTRATE | CONOPCO INC., D/B/A UNILEVER (US) | 2021-03-25 | — | — | US | disclosed |
| US-20210032759-A1 | CORROSION INHIBITOR COMPOSITION AND METHODS OF INHIBITING CORROSION DURING ACID PICKLING | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2021-02-04 | — | — | US | disclosed |
| US-10888593-B2 | Use of pectin or pectin-related saccharides to enhance efficacy of plant growth-promoting rhizobacteria (PGPR) strains for promoting growth and health in plants and animals | AUBURN UNIVERSITY (US) | 2021-01-12 | — | — | US | disclosed |
| CN-107205403-B | Use of pectin or pectin-related saccharides to increase the efficacy of plant growth-promoting rhizobacteria (PGPR) strains to promote growth and health in plants and animals | 奥本大学 | 2021-01-08 | — | — | CN | disclosed |
| US-20200352854-A1 | DEVICES AND METHODS FOR PREVENTING AND INHIBITING PERIODONTAL DISEASE | Fixed Focus LLC (US) | 2020-11-12 | — | — | US | disclosed |
| EP-3720449-A1 | COMPOSITION FOR USE IN THE PREVENTION OR TREATMENT OF SALMONELLOSIS | NutriLeads B.V. (NL) | 2020-10-14 | — | — | EP | disclosed |
| EP-1913073-B2 | OIL-IN-WATER EMULSIONS | HENKEL AG & CO KGAA (DE) | 2020-10-14 | — | — | EP | disclosed |
| CN-111683546-A | Enzymatically hydrolyzed pectin polysaccharides for treating or preventing infections | 纽崔莱公司 | 2020-09-18 | — | — | CN | disclosed |
| CN-111683540-A | Method for producing pectin polysaccharide isolate rich in rhamnogalacturonan-I | 纽崔莱公司 | 2020-09-18 | — | — | CN | disclosed |
| US-20200289545-A1 | COMPOSITION FOR USE IN THE PREVENTION OR TREATMENT OF SALMONELLOSIS | NUTRILEADS B.V. (NL) | 2020-09-17 | — | — | US | disclosed |
| EP-3200590-B1 | USE OF PECTIN OR PECTIN-RELATED SACCHARIDES TO ENHANCE EFFICACY OF PLANT GROWTH-PROMOTING RHIZOBACTERIA (PGPR) STRAINS FOR PROMOTING GROWTH AND HEALTH IN PLANTS | UNIV AUBURN (US) | 2020-09-02 | — | — | EP | disclosed |
| EP-3700350-A1 | METHOD OF PRODUCING A PECTIC POLYSACCHARIDE ISOLATE ENRICHED IN RHAMNOGALACTURONAN-I | NutriLeads B.V. (NL) | 2020-09-02 | — | — | EP | disclosed |
| EP-3700357-A1 | ENZYMATICALLY HYDROLYSED PECTIC POLYSACCHARIDES FOR TREATING OR PREVENTING INFECTIONS | NutriLeads B.V. (NL) | 2020-09-02 | — | — | EP | disclosed |
| CN-111574579-A | Preparation method of dammarane type saponin and application of dammarane type saponin in preparation of hypoglycemic and anti-inflammatory drugs and health-care products | 广西师范大学 | 2020-08-25 | — | — | CN | disclosed |
| US-20200247912-A1 | METHOD OF PRODUCING A PECTIC POLYSACCHARIDE ISOLATE ENRICHED IN RHAMNOGALACTURONAN-I | NUTRILEADS B.V. (NL) | 2020-08-06 | — | — | US | disclosed |
| US-20200246373-A1 | ENZYMATICALLY HYDROLYSED PECTIC POLYSACCHARIDES FOR TREATING OR PREVENTING INFECTIONS | NUTRILEADS B.V. (NL) | 2020-08-06 | — | — | US | disclosed |
| CN-111447935-A | Composition for preventing or treating salmonellosis | 纽崔利兹有限公司 | 2020-07-24 | — | — | CN | disclosed |
| EP-3679924-A2 | FORMULATION COMPRISING PARTICLES | perora GmbH (DE) | 2020-07-15 | — | — | EP | disclosed |
| US-20200188425-A1 | FOOD AND/OR FEED COMPOSITIONS FOR PREVENTING AND TREATING INFLAMMATORY DISEASES | DSM IP ASSETS B.V. (NL) | 2020-06-18 | — | — | US | disclosed |
| CN-107903291-B | Chromone glycoside compound extracted from divaricate saposhnikovia root and method and application thereof | 成都普思生物科技股份有限公司 | 2020-05-22 | — | — | CN | disclosed |
| US-10639323-B2 | Feed compositions for preventing and treating inflammatory diseases | NUTRITION SCIENCES N.V. (BE) | 2020-05-05 | — | — | US | disclosed |
| US-20200101104-A1 | FOOD COMPOSITIONS FOR MANAGING BODY WEIGHT | DSM IP ASSETS BV (NL) | 2020-04-02 | — | — | US | disclosed |
| CN-110922444-A | Panaxadiol type triterpenoid saponin with anti-inflammatory activity | 天津中医药大学 | 2020-03-27 | — | — | CN | disclosed |
| US-20200071736-A1 | METHOD FOR THE ENZYMATIC SACCHARIFICATION OF A POLYSACCHARIDE | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2020-03-05 | — | — | US | disclosed |
| EP-3612040-A1 | A SAVOURY CONCENTRATE | Unilever N.V. (NL) | 2020-02-26 | — | — | EP | disclosed |
| EP-3188713-B1 | METHOD OF INDUCING SATIETY | PERORA GMBH (DE) | 2020-02-12 | — | — | EP | disclosed |
| US-20190328025-A1 | HIGHLY STABLE AERATED OIL-IN-WATER EMULSION | CSM BAKERY SOLUTIONS EUROPE HOLDING B.V. (NL) | 2019-10-31 | — | — | US | disclosed |
| US-20190256875-A1 | IMPROVED MESO-GALACTARIC ACID PRODUCTION FROM GALACTURONIC ACID WITH GENETICALLY MODIFIED FUNGAL CELLS | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2019-08-22 | — | — | US | disclosed |
| EP-3519567-A1 | ENGINEERED MICROORGANISMS FOR PRODUCTION OF COMMODITY CHEMICALS AND CELLULAR BIOMASS | The Regents of The University of California (US) | 2019-08-07 | — | — | EP | disclosed |
| US-20190218313-A1 | PROCESS FOR EXTRACTION OF PECTIN | DUPONT NUTRITION BIOSCI APS (DK) | 2019-07-18 | — | — | US | disclosed |
| US-20190218527-A1 | Engineered Microorganisms for Production of Commodity Chemicals and Cellular Biomass | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-07-18 | — | — | US | disclosed |
| US-20190200634-A1 | BASE EMULSION FOR THE PREPARATION OF ICINGS, FILLINGS AND TOPPINGS | CSM BAKERY SOLUTIONS EUROPE HOLDING B.V. (NL) | 2019-07-04 | — | — | US | disclosed |
| US-20190201437-A1 | FOOD COMPOSITIONS FOR MANAGING BODY WEIGHT | DSM IP ASSETS B.V. (NL) | 2019-07-04 | — | — | US | disclosed |
| WO-2019112418-A1 | COMPOSITION FOR USE IN THE PREVENTION OR TREATMENT OF SALMONELLOSIS | NUTRILEADS B.V. (NL) | 2019-06-13 | — | — | WO | disclosed |
| EP-3458578-A1 | IMPROVED MESO-GALACTARIC ACID PRODUCTION FROM GALACTURONIC ACID WITH GENETICALLY MODIFIED FUNGAL CELLS | Teknologian Tutkimuskeskus VTT OY (FI) | 2019-03-27 | — | — | EP | disclosed |
| WO-2018231565-A9 | GREEN BIOMASS MODIFICATION | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2019-01-24 | — | — | WO | disclosed |
| US-20190008890-A1 | FEED COMPOSITIONS FOR PREVENTING AND TREATING INFLAMMATORY DISEASES | NUTRITION SCIENCES N.V. (BE) | 2019-01-10 | — | — | US | disclosed |
| WO-2018231565-A1 | GREEN BIOMASS MODIFICATION | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2018-12-20 | — | — | WO | disclosed |
| WO-2018192748-A1 | A SAVOURY CONCENTRATE | UNILEVER N.V. (NL) | 2018-10-25 | — | — | WO | disclosed |
| WO-2018157248-A1 | METHOD FOR THE ENZYMATIC SACCHARIFICATION OF A POLYSACCHARIDE | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2018-09-07 | — | — | WO | disclosed |
| US-20180237573-A1 | POLYESTER POLYOLS FROM RECYCLED POLYMERS AND WASTE STREAMS | RESINATE MAT GROUP INC (US) | 2018-08-23 | — | — | US | disclosed |
| US-20180214411-A1 | COMPOSITION COMPRISING SATIETY-INDUCING PARTICLES | PERORA GMBH (DE) | 2018-08-02 | — | — | US | disclosed |
| US-20180199596-A1 | PECTINS IMPROVING ENERGY REDISTRIBUTION IN ANIMALS | NUTRITION SCIENCES N.V. (BE) | 2018-07-19 | — | — | US | disclosed |
| WO-2018127486-A1 | ENZYMATIC DEHUSKING OF PULSES | NOVOZYMES A/S (DK) | 2018-07-12 | — | — | WO | disclosed |
| US-20180193375-A1 | FOOD AND/OR FEED COMPOSITIONS FOR PREVENTING AND TREATING INFLAMMATORY DISEASES | DSM IP ASSETS B.V. (NL) | 2018-07-12 | — | — | US | disclosed |
| US-20180185327-A1 | FORMULATION COMPRISING PARTICLES AND A LIPASE INHIBITOR | PERORA GMBH (DE) | 2018-07-05 | — | — | US | disclosed |
| EP-3319589-A1 | COMPOSITION COMPRISING SATIETY-INDUCING PARTICLES | perora GmbH (DE) | 2018-05-16 | — | — | EP | disclosed |
| EP-3319616-A2 | FEED COMPOSITIONS FOR PREVENTING AND TREATING INFLAMMATORY DISEASES | Nutrition Sciences N.V. (BE) | 2018-05-16 | — | — | EP | disclosed |
| EP-3319590-A1 | FORMULATION COMPRISING PARTICLES AND A LIPASE INHIBITOR | perora GmbH (DE) | 2018-05-16 | — | — | EP | disclosed |
| EP-3319615-A1 | FOOD AND/OR FEED COMPOSITIONS FOR PREVENTING AND TREATING INFLAMMATORY DISEASES | DSM IP Assets B.V. (NL) | 2018-05-16 | — | — | EP | disclosed |
| EP-3319457-A1 | PECTINS IMPROVING ENERGY REDISTRIBUTION IN ANIMALS | Nutrition Sciences N.V. (BE) | 2018-05-16 | — | — | EP | disclosed |
| EP-3319617-A1 | FOOD COMPOSITIONS FOR MANAGING BODY WEIGHT | DSM IP Assets B.V. (NL) | 2018-05-16 | — | — | EP | disclosed |
| EP-2238967-B1 | Skin treatment fighting skin aging II | HENKEL AG & CO KGAA (DE) | 2018-05-02 | — | — | EP | disclosed |
| EP-2238968-B1 | Skin treatment fighting skin aging | HENKEL AG & CO KGAA (DE) | 2018-05-02 | — | — | EP | disclosed |
| EP-3310817-A1 | PROCESS FOR EXTRACTION OF PECTIN | DuPont Nutrition Biosciences ApS (DK) | 2018-04-25 | — | — | EP | disclosed |
| US-9951171-B2 | Polyester polyols from recycled polymers and waste streams | RESINATE MATERIALS GROUP, INC. (US) | 2018-04-24 | — | — | US | disclosed |
| CN-107920558-A | Pectin for improving energy redistribution in animals | 营养科学股份有限公司 | 2018-04-17 | — | — | CN | disclosed |
| CN-107921057-A | For preventing and treating the combination of pectins of inflammatory disease | 营养科学股份有限公司 | 2018-04-17 | — | — | CN | disclosed |
| WO-2018067458-A1 | ENGINEERED MICROORGANISMS FOR PRODUCTION OF COMMODITY CHEMICALS AND CELLULAR BIOMASS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-04-12 | — | — | WO | disclosed |
| US-9896540-B2 | Polyester polyols from recycled polymers and waste streams | RESINATE MATERIALS GROUP, INC. (US) | 2018-02-20 | — | — | US | disclosed |
| US-20180035678-A1 | EMULSION BASE FOR THE PREPARATION OF ICINGS AND FILLINGS | CSM BAKERY SOLUTIONS EUROPE HOLDING B.V. (NL) | 2018-02-08 | — | — | US | disclosed |
| US-20180035691-A1 | HIGHLY STABLE AERATED OIL-IN-WATER EMULSION | CSM BAKERY SOLUTIONS EUROPE HOLDING B.V. (NL) | 2018-02-08 | — | — | US | disclosed |
| WO-2018024823-A1 | BASE EMULSION FOR THE PREPARATION OF ICINGS, FILLINGS AND TOPPINGS | CSM BAKERY SOLUTIONS EUROPE HOLDING B.V. (NL) | 2018-02-08 | — | — | WO | disclosed |
| WO-2018024821-A1 | HIGHLY STABLE AERATED OIL-IN-WATER EMULSION | CSM BAKERY SOLUTIONS EUROPE HOLDING B.V. (NL) | 2018-02-08 | — | — | WO | disclosed |
| WO-2017198908-A1 | IMPROVED MESO-GALACTARIC ACID PRODUCTION FROM GALACTURONIC ACID WITH GENETICALLY MODIFIED FUNGAL CELLS | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2017-11-23 | — | — | WO | disclosed |
| WO-2017187194-A1 | SOLID DOSAGE FORM | UNIVERSITY OF CENTRAL LANCASHIRE (GB) | 2017-11-02 | — | — | WO | disclosed |
| EP-3233979-A1 | METHOD FOR PREPARING A POLYMER MATERIAL MADE FROM PLANT MATERIAL | Université de Picardie Jules Verne (FR) | 2017-10-25 | — | — | EP | disclosed |
| US-9788561-B2 | Tomato fibre composition and method for the preparation thereof | CONOPCO, INC. (US) | 2017-10-17 | — | — | US | disclosed |
| EP-1913073-B1 | OIL-IN-WATER EMULSIONS | HENKEL AG & CO KGAA (DE) | 2017-10-04 | — | — | EP | disclosed |
| US-20170258824-A1 | METHOD OF INDUCING SATIETY | Wörwag Pharma GmbH & Co.KG (DE) | 2017-09-14 | — | — | US | disclosed |
| US-20170258725-A1 | FORMULATION COMPRISING PARTICLES | Wörwag Pharma GmbH & Co.KG (DE) | 2017-09-14 | — | — | US | disclosed |
| EP-3200590-A1 | USE OF PECTIN OR PECTIN-RELATED SACCHARIDES TO ENHANCE EFFICACY OF PLANT GROWTH-PROMOTING RHIZOBACTERIA (PGPR) STRAINS FOR PROMOTING GROWTH AND HEALTH IN PLANTS AND ANIMALS | Auburn University (US) | 2017-08-09 | — | — | EP | disclosed |
| US-20170202888-A1 | USE OF PECTIN OR PECTIN-RELATED SACCHARIDES TO ENHANCE EFFICACY OF PLANT GROWTH-PROMOTING RHIZOBACTERIA (PGPR) STRAINS FOR PROMOTING GROWTH AND HEALTH IN PLANTS AND ANIMALS | AUBURN UNIVERSITY (US) | 2017-07-20 | — | — | US | disclosed |
| WO-2017120385-A1 | POLYMERIC COMPOSITIONS AND RELATED SYSTEMS AND METHODS FOR REGULATING BIOLOGICAL HYDROGELS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2017-07-13 | — | — | WO | disclosed |
| EP-3188717-A1 | FORMULATION COMPRISING PARTICLES | perora GmbH (DE) | 2017-07-12 | — | — | EP | disclosed |
| EP-3188713-A1 | METHOD OF INDUCING SATIETY | perora GmbH (DE) | 2017-07-12 | — | — | EP | disclosed |
| US-20170189444-A1 | POLYMERIC COMPOSITIONS AND RELATED SYSTEMS AND METHODS FOR REGULATING BIOLOGICAL HYDROGELS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2017-07-06 | — | — | US | disclosed |
| EP-3183286-A1 | POLYESTER POLYOLS FROM RECYCLED POLYMERS AND WASTE STREAMS | Resinate Materials Group, Inc. (US) | 2017-06-28 | — | — | EP | disclosed |
| EP-1938784-B1 | Pre-treatment agent for protecting the scalp | HENKEL AG & CO KGAA (DE) | 2017-02-08 | — | — | EP | disclosed |
| US-20170029561-A1 | POLYESTER POLYOLS FROM RECYCLED POLYMERS AND WASTE STREAMS | RESINATE MATERIALS GROUP, INC. | 2017-02-02 | — | — | US | disclosed |
| WO-2017009259-A1 | PECTINS IMPROVING ENERGY REDISTRIBUTION IN ANIMALS | NUTRITION SCIENCES N.V. (BE) | 2017-01-19 | — | — | WO | disclosed |
| WO-2017009203-A1 | FOOD COMPOSITIONS FOR MANAGING BODY WEIGHT | DSM IP ASSETS B.V. (NL) | 2017-01-19 | — | — | WO | disclosed |
| WO-2017009202-A1 | FOOD AND/OR FEED COMPOSITIONS FOR PREVENTING AND TREATING INFLAMMATORY DISEASES | DSM IP ASSETS B.V. (NL) | 2017-01-19 | — | — | WO | disclosed |
| WO-2017009257-A2 | FEED COMPOSITIONS FOR PREVENTING AND TREATING INFLAMMATORY DISEASES | NUTRITION SCIENCES N.V. (BE) | 2017-01-19 | — | — | WO | disclosed |
| WO-2017005887-A1 | COMPOSITION COMPRISING SATIETY-INDUCING PARTICLES | PERORA GMBH (DE) | 2017-01-12 | — | — | WO | disclosed |
| WO-2017005888-A1 | FORMULATION COMPRISING PARTICLES AND A LIPASE INHIBITOR | PERORA GMBH (DE) | 2017-01-12 | — | — | WO | disclosed |
| EP-2349182-B1 | FOAMING EMULSIONS | HENKEL AG & CO KGAA (DE) | 2017-01-04 | — | — | EP | disclosed |
| WO-2016202986-A1 | PROCESS FOR EXTRACTION OF PECTIN | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2016-12-22 | — | — | WO | disclosed |
| CN-106138501-A | A kind of Chinese medicine composition treating dog eczema and its production and use | 南京金盾动物药业有限责任公司 | 2016-11-23 | — | — | CN | disclosed |
| EP-3083703-A1 | PROCESS FOR EXTRACTION OF CALCIUM SENSITIVE PECTIN | DuPont Nutrition Biosciences ApS (DK) | 2016-10-26 | — | — | EP | disclosed |
| EP-1852102-B1 | Method for manufacturing oil in water emulsions for roll-on applications | HENKEL AG & CO KGAA (DE) | 2016-10-05 | — | — | EP | disclosed |
| CN-105829356-A | Extraction method of calcium-sensitive pectin | 杜邦营养生物科学有限公司 | 2016-08-03 | — | — | CN | disclosed |
| US-9374955-B2 | Compositions and methods for anti-transpiration in plants | INNOVATION HAMMER, LLC (US) | 2016-06-28 | — | — | US | disclosed |
| WO-2016097583-A1 | METHOD FOR PREPARING A POLYMER MATERIAL MADE FROM PLANT MATERIAL | Université de Picardie Jules Verne (FR) | 2016-06-23 | — | — | WO | disclosed |
| EP-2934179-B1 | A TOMATO FIBRE COMPOSITION AND METHOD FOR THE PREPARATION THEREOF | UNILEVER NV (NL) | 2016-06-15 | — | — | EP | disclosed |
| EP-1803435-B1 | Cosmetic sun protection compositions based on lamelliform emulsions | HENKEL AG & CO KGAA (DE) | 2016-06-08 | — | — | EP | disclosed |
| EP-2866583-B1 | EDIBLE OIL-IN-WATER EMULSION | UNILEVER NV (NL) | 2016-05-25 | — | — | EP | disclosed |
| CN-104116684-B | A kind of pure natural shower powder | GUO HONGGANG (CN) | 2016-05-25 | — | — | CN | disclosed |
| WO-2016054222-A1 | USE OF PECTIN OR PECTIN-RELATED SACCHARIDES TO ENHANCE EFFICACY OF PLANT GROWTH-PROMOTING RHIZOBACTERIA (PGPR) STRAINS FOR PROMOTING GROWTH AND HEALTH IN PLANTS AND ANIMALS | AUBURN UNIVERSITY (US) | 2016-04-07 | — | — | WO | disclosed |
| US-9277697-B2 | Compositions and methods for anti-transpiration in plants | INNOVATION HAMMER, LLC (US) | 2016-03-08 | — | — | US | disclosed |
| EP-2633887-B1 | Novel agent combination for efficient anti-wrinkle effect | HENKEL AG&CO KGAA (DE) | 2016-03-02 | — | — | EP | disclosed |
| US-20160053058-A1 | POLYESTER POLYOLS FROM RECYCLED POLYMERS AND WASTE STREAMS | RESINATE MATERIALS GROUP INC (US) | 2016-02-25 | — | — | US | disclosed |
| WO-2016028837-A1 | POLYESTER POLYOLS FROM RECYCLED POLYMERS AND WASTE STREAMS | RESINATE MATERIALS GROUP, INC. (US) | 2016-02-25 | — | — | WO | disclosed |
| WO-2016023924-A1 | METHOD OF INDUCING SATIETY | PERORA GMBH (DE) | 2016-02-18 | — | — | WO | disclosed |
| WO-2016023923-A1 | FORMULATION COMPRISING PARTICLES | PERORA GMBH (DE) | 2016-02-18 | — | — | WO | disclosed |
| US-20150335054-A1 | A TOMATO FIBRE COMPOSITION AND METHOD FOR THE PREPARATION THEREOF | CONOPCO, INC., D/B/A UNILEVER (US) | 2015-11-26 | — | — | US | disclosed |
| EP-2934179-A1 | A TOMATO FIBRE COMPOSITION AND METHOD FOR THE PREPARATION THEREOF | Unilever N.V. (NL) | 2015-10-28 | — | — | EP | disclosed |
| EP-2023888-B1 | QUICK-DRYING COSMETIC EMULSIONS FOR ROLL-ON APPLICATION | HENKEL AG & CO KGAA (DE) | 2015-10-07 | — | — | EP | disclosed |
| US-20150250171-A1 | Compositions And Methods For Anti-Transpiration In Plants | INNOVATION HAMMER LLC (US) | 2015-09-10 | — | — | US | disclosed |
| US-20150250117-A1 | Compositions And Methods For Anti-Transpiration In Plants | INNOVATION HAMMER LLC (US) | 2015-09-10 | — | — | US | disclosed |
| CN-104902763-A | A tomato fibre composition and method for the preparation thereof | UNILEVER NV | 2015-09-09 | — | — | CN | disclosed |
| US-9072304-B2 | Compositions and methods for anti-transpiration in plants | INNOVATION HAMMER, LLC (US) | 2015-07-07 | — | — | US | disclosed |
| WO-2015091629-A1 | PROCESS FOR EXTRACTION OF CALCIUM SENSITIVE PECTIN | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2015-06-25 | — | — | WO | disclosed |
| EP-2878341-A2 | Application of cosmetic compositions for the inactivation and/or elimination of skin mites | Henkel AG & Co. KGaA (DE) | 2015-06-03 | — | — | EP | disclosed |
| EP-2878292-A2 | Application of cosmetic compositions for the inactivation and/or elimination of skin mites | Henkel AG & Co. KGaA (DE) | 2015-06-03 | — | — | EP | disclosed |
| EP-2866583-A1 | EDIBLE OIL-IN-WATER EMULSION | Unilever N.V. (NL) | 2015-05-06 | — | — | EP | disclosed |
| CN-104592207-A | Novel monosaccharide fluorescence derivation method and applications thereof | UNIV NANJING AGRICULTURAL | 2015-05-06 | — | — | CN | disclosed |
| EP-2372779-B9 | Alkaline etching liquid for texturing a silicon wafer surface | SOLARWORLD IND AMERICA INC (US) | 2015-01-07 | — | — | EP | disclosed |
| EP-2372779-B1 | Alkaline etching liquid for texturing a silicon wafer surface | SOLARWORLD IND AMERICA INC (US) | 2014-10-01 | — | — | EP | disclosed |
| EP-2026664-B1 | ONE STEP SPRAY-DRYING PROCESS | FIRMENICH & CIE (CH) | 2014-09-10 | — | — | EP | disclosed |
| WO-2014095342-A1 | A TOMATO FIBRE COMPOSITION AND METHOD FOR THE PREPARATION THEREOF | UNILEVER N.V. (NL) | 2014-06-26 | — | — | WO | disclosed |
| WO-2014001030-A1 | EDIBLE OIL-IN-WATER EMULSION | UNILEVER N.V. (NL) | 2014-01-03 | — | — | WO | disclosed |
| WO-2014001016-A1 | EDIBLE OIL-IN-WATER EMULSION | UNILEVER N.V. (NL) | 2014-01-03 | — | — | WO | disclosed |
| US-20130334667-A1 | Alkaline Etching Liquid for Texturing a Silicon Wafer Surface | SOLARWORLD INDUSTRIES AMERICA, INC. (US) | 2013-12-19 | — | — | US | disclosed |
| EP-2091502-B1 | O/W EMULSION | HENKEL AG & CO KGAA (DE) | 2013-12-18 | — | — | EP | disclosed |
| US-20130330797-A1 | Process for Producing Biogas from Pectin and Lignocellulose Containing Material | NOVOZYMES A/S (DK) | 2013-12-12 | — | — | US | disclosed |
| EP-2661499-A1 | PROCESS FOR PRODUCING BIOGAS FROM PECTIN AND LIGNOCELLULOSE CONTAINING MATERIAL | Novozymes A/S (DK) | 2013-11-13 | — | — | EP | disclosed |
| CN-103339260-A | Method for producing biogas from pectin-and lignocellulose-containing material | NOVOZYMES AS | 2013-10-02 | — | — | CN | disclosed |
| EP-2633887-A1 | Novel agent combination for efficient anti-wrinkle effect | Henkel AG&Co. KGAA (DE) | 2013-09-04 | — | — | EP | disclosed |
| EP-2628479-A1 | Cosmetic use of climbazol | Henkel AG&Co. KGAA (DE) | 2013-08-21 | — | — | EP | disclosed |
| WO-2013091975-A1 | BIOMIMETIC COMPOSITIONS FOR SKIN CLEANSING AND SKIN CARE | HENKEL AG & CO. KGAA (DE) | 2013-06-27 | — | — | WO | disclosed |
| EP-2601931-A2 | Cosmetic use of 3-methyl-1-phenyl-5-pyrazolon | Henkel AG&Co. KGAA (DE) | 2013-06-12 | — | — | EP | disclosed |
| CN-101528058-B | Improved thickener composition for food products | LUBRIZOL ADVANCED MAT INC | 2013-05-22 | — | — | CN | disclosed |
| EP-2591767-A2 | Skin-firming cosmetic compositions with pleasant feeling on use | Henkel AG & Co. KGaA (DE) | 2013-05-15 | — | — | EP | disclosed |
| CN-101448408-B | One-step spray drying process | FIRMENICH & CIE | 2013-02-13 | — | — | CN | disclosed |
| EP-2552234-A1 | SPRAY-DRIED CRYSTALLINE ACTIVE INGREDIENT | Firmenich S.A. (CH) | 2013-02-06 | — | — | EP | disclosed |
| US-20130028976-A1 | SPRAY-DRIED CRYSTALLINE ACTIVE INGREDIENT | FIRMENICH SA (CH) | 2013-01-31 | — | — | US | disclosed |
| CN-102802436-A | Spray-dried crystalline active ingredient | FIRMENICH & CIE | 2012-11-28 | — | — | CN | disclosed |
| EP-2514401-A2 | Cosmetic and dermatological compounds for dry skin | Henkel AG & Co. KGaA (DE) | 2012-10-24 | — | — | EP | disclosed |
| WO-2012093041-A1 | PROCESS FOR PRODUCING BIOGAS FROM PECTIN AND LIGNOCELLULOSE CONTAINING MATERIAL | NOVOZYMES A/S (DK) | 2012-07-12 | — | — | WO | disclosed |
| EP-2451434-A2 | ACTIVE-INGREDIENT COMBINATION FOR TREATING MATURE SKIN II | Henkel AG & Co. KGaA (DE) | 2012-05-16 | — | — | EP | disclosed |
| US-20120112321-A1 | ALKALINE ETCHING LIQUID FOR TEXTURING A SILICON WAFER SURFACE | SOLARWORLD INDUSTRIES AMERICA, INC. (US) | 2012-05-10 | — | — | US | disclosed |
| EP-2097059-B1 | CLEANSING OR CARE PRODUCT | HENKEL KGAA (DE) | 2012-04-18 | — | — | EP | disclosed |
| US-20120077679-A1 | Compositions And Methods For Anti-Transpiration In Plants | INNOVATION HAMMER, LLC | 2012-03-29 | — | — | US | disclosed |
| CN-101252845-B | Encapsulated active ingredients, method of preparation and use thereof | FIRMENICH & CIE | 2012-03-28 | — | — | CN | disclosed |
| US-8093182-B2 | Compositions and methods for anti-transpiration in plants | INNOVATION HAMMER, LLC | 2012-01-10 | — | — | US | disclosed |
| WO-2011121515-A1 | SPRAY-DRIED CRYSTALLINE ACTIVE INGREDIENT | FIRMENICH SA (CH) | 2011-10-06 | — | — | WO | disclosed |
| EP-2372779-A2 | Alkaline etching liquid for texturing a silicon wafer surface | SolarWorld Industries America, Inc. (US) | 2011-10-05 | — | — | EP | disclosed |
| US-20110224159-A1 | BIDESMOSIDIC BETULIN AND BETULINIC ACID DERIVATIVES AND USES THEREOF AS ANTITUMOR AGENTS | Universite du Quebec a Chicoutime (CA) | 2011-09-15 | — | — | US | disclosed |
| US-20110206811-A1 | SEMI-SOLID HONEY-BASED PRODUCTS | NATURAL BITS FOOD DESIGN LTD. (IL) | 2011-08-25 | — | — | US | disclosed |
| EP-2352390-A1 | SEMI-SOLID HONEY-BASED PRODUCTS | Natural Bits Food Design Ltd. (IL) | 2011-08-10 | — | — | EP | disclosed |
| EP-2349183-A2 | FOAMING EMULSIONS CONTAINING POLYMERS | Henkel AG & Co. KGaA (DE) | 2011-08-03 | — | — | EP | disclosed |
| EP-2349182-A2 | FOAMING EMULSIONS | Henkel AG & Co. KGaA (DE) | 2011-08-03 | — | — | EP | disclosed |
| EP-2349181-A1 | FOAMING EMULSIONS COMPRISING A COMBINATION OF EMULSIFIERS | Henkel AG & Co. KGaA (DE) | 2011-08-03 | — | — | EP | disclosed |
| EP-2346487-A2 | ACTIVE INGREDIENT COMBINATION FOR THE TREATMENT OF MATURE SKIN I | Henkel AG & Co. KGaA (DE) | 2011-07-27 | — | — | EP | disclosed |
| US-20110172102-A1 | USE OF OLIGOAPIOGALACTURONANS AND THEIR DERIVATIVES TO SIMULATE DEFENCE AND RESISTANCE REACTIONS IN PLANTS AGAINST BIOTIC AND ABIOTIC STRESS SOURCES | ALGIE PLUS (FR) | 2011-07-14 | — | — | US | disclosed |
| WO-2011079971-A2 | COSMETICS CONTAINING EUK-134 AND/OR EUK-118 AND AT LEAST ONE COSMETIC CARE SUBSTANCE | HENKEL AG & CO. KGAA (DE) | 2011-07-07 | — | — | WO | disclosed |
| EP-2317848-A2 | USE OF APIOGALACTURONANES FOR STIMULATING THE REACTIONS OF DEFENCE AND RESISTANCE TO BIOTIC AND ABIOTIC STRESS IN PLANTS | Algie Plus (FR) | 2011-05-11 | — | — | EP | disclosed |
| CN-102038975-A | Chinese medicinal herbal plant liquid cotton gauze sanitary towel | MINGJIE LI | 2011-05-04 | — | — | CN | disclosed |
| US-20110020226-A1 | PARTICLE STRUCTURES COMPRISING STEROLS AND SAPONINS | NORDIC VACCINE TECHNOLOGY A/S | 2011-01-27 | — | — | US | disclosed |
| EP-2081446-B1 | IMPROVED THICKENER COMPOSITION FOR FOOD PRODUCTS | LUBRIZOL ADVANCED MAT INC (US) | 2011-01-19 | — | — | EP | disclosed |
| EP-2266529-A2 | UV protection cosmetic product | Henkel AG & Co. KGaA (DE) | 2010-12-29 | — | — | EP | disclosed |
| EP-2241353-A2 | Foaming emulsions with polymers | Henkel AG & Co. KGaA (DE) | 2010-10-20 | — | — | EP | disclosed |
| EP-2238967-A2 | Skin treatment fighting skin aging II | Henkel AG & Co. KGaA (DE) | 2010-10-13 | — | — | EP | disclosed |
| EP-2238968-A2 | Skin treatment fighting skin aging | Henkel AG & Co. KGaA (DE) | 2010-10-13 | — | — | EP | disclosed |
| CN-1980578-B | Encapsulated hydrophilic compounds | FIRMENICH & CIE | 2010-10-13 | — | — | CN | disclosed |
| EP-2223679-A2 | Cellular rejuvenation compounds | Henkel AG & Co. KGaA (DE) | 2010-09-01 | — | — | EP | disclosed |
| EP-2196184-A1 | Hair dye with colour indicator | Henkel AG & Co. KGaA (DE) | 2010-06-16 | — | — | EP | disclosed |
| WO-2010060895-A2 | FOAMING EMULSIONS CONTAINING POLYMERS | HENKEL AG & CO. KGAA (DE) | 2010-06-03 | — | — | WO | disclosed |
| WO-2010060894-A2 | FOAMING EMULSIONS | HENKEL AG & CO. KGAA (DE) | 2010-06-03 | — | — | WO | disclosed |
| WO-2010060896-A1 | FOAMING EMULSIONS COMPRISING A COMBINATION OF EMULSIFIERS | HENKEL AG & CO. KGAA (DE) | 2010-06-03 | — | — | WO | disclosed |
| WO-2010052703-A1 | SEMI-SOLID HONEY-BASED PRODUCTS | NATURAL BITS FOOD DESIGN LTD. (IL) | 2010-05-14 | — | — | WO | disclosed |
| US-7713942-B2 | Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides | NORDIC VACCINE TECHNOLOGY A/S (DK) | 2010-05-11 | — | — | US | disclosed |
| WO-2010049011-A2 | ACTIVE-INGREDIENT COMBINATION FOR TREATING MATURE SKIN II | HENKEL AG & CO. KGAA (DE) | 2010-05-06 | — | — | WO | disclosed |
| WO-2010049457-A2 | ACTIVE INGREDIENT COMBINATION FOR THE TREATMENT OF MATURE SKIN I | HENKEL AG & CO. KGAA (DE) | 2010-05-06 | — | — | WO | disclosed |
| WO-2010049390-A1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS FOR THE REDUCTION OF FACIAL EXPRESSION WRINKLES | HENKEL AG & CO. KGAA (DE) | 2010-05-06 | — | — | WO | disclosed |
| EP-2167017-A2 | COSMETIC STICK BASED ON A CONGEALED OIL-IN-WATER DISPERSION/EMULSION HAVING A HYDROGEL FORMER | Henkel AG & Co. KGaA (DE) | 2010-03-31 | — | — | EP | disclosed |
| EP-2167018-A2 | COSMETIC STICK BASED ON A CONGEALED OIL-IN-WATER DISPERSION/EMULSION | Henkel AG & Co. KGaA (DE) | 2010-03-31 | — | — | EP | disclosed |
| US-20100047296-A1 | Low-Residue Cosmetic Or Dermatological Stick Based On An Oil-In-Water Dispersion/Emulsion III | HENKEL AG & CO. KGAA (DE) | 2010-02-25 | — | — | US | disclosed |
| WO-2010017956-A2 | USE OF OLIGO-APIOGALACTURONANS AND THE DERIVATIVES THEREOF FOR STIMULATING DEFENCE AND RESISTANCE REACTIONS OF PLANTS AGAINST BIOTIC AND ABIOTIC STRESSES | ALGIE PLUS (FR) | 2010-02-18 | — | — | WO | disclosed |
| US-20100034923-A1 | ENHANCING THE EFFECTIVE CONCENTRATION OF LYSOZYME IN WINE | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY | 2010-02-11 | — | — | US | disclosed |
| US-20090252789-A1 | ONE STEP SPRAY-DRYING PROCESS | FIRMENICH SA (CH) | 2009-10-08 | — | — | US | disclosed |
| EP-1530480-B1 | COSMETIC COMPOSITION COMPRISING MONOSACCHARIDES OR POLYSACCHARIDES, USES AND TREATMENT METHODS | SOC EXTRACTION PRINCIPES ACTIF (FR) | 2009-09-30 | — | — | EP | disclosed |
| EP-2097059-A1 | CLEANSING OR CARE PRODUCT | Henkel Kommanditgesellschaft auf Aktien (DE) | 2009-09-09 | — | — | EP | disclosed |
| CN-101528058-A | Improved thickener composition for food products | LUBRIZOL ADVANCED MAT INC (US) | 2009-09-09 | — | — | CN | disclosed |
| EP-2091502-A1 | O/W EMULSION | Henkel AG & Co. KGaA (DE) | 2009-08-26 | — | — | EP | disclosed |
| EP-2081446-A1 | IMPROVED THICKENER COMPOSITION FOR FOOD PRODUCTS | Lubrizol Advanced Materials, Inc. (US) | 2009-07-29 | — | — | EP | disclosed |
| EP-2076235-A2 | LOW-RESIDUE COSMETIC OR DERMATOLOGICAL STICK BASED ON AN OIL-IN-WATER DISPERSION/EMULSION III | Henkel AG & Co. KGaA (DE) | 2009-07-08 | — | — | EP | disclosed |
| CN-101448408-A | One-step spray drying process | FIRMENICH & CIE (CH) | 2009-06-03 | — | — | CN | disclosed |
| EP-1924156-B1 | ENCAPSULATED ACTIVE INGREDIENTS, METHODS OF PREPARATION AND THEIR USE | FIRMENICH & CIE (CH) | 2009-05-06 | — | — | EP | disclosed |
| EP-1671673-B1 | Pigments containing water-in-siliconoil-emulsion for improving the appearance of the skin | HENKEL AG & CO KGAA (DE) | 2009-04-22 | — | — | EP | disclosed |
| EP-2026664-A2 | ONE STEP SPRAY-DRYING PROCESS | Firmenich S.A. (CH) | 2009-02-25 | — | — | EP | disclosed |
| US-20090047226-A1 | Quick-drying cosmetic emulsions for roll-on application | HENKEL AG & C. KGAA (DE) | 2009-02-19 | — | — | US | disclosed |
| EP-2023888-A2 | QUICK-DRYING COSMETIC EMULSIONS FOR ROLL-ON APPLICATION | Henkel AG & Co. KGaA (DE) | 2009-02-18 | — | — | EP | disclosed |
| EP-2020986-A2 | COSMETIC USE OF A ZOSTERA MARINA EXTRACT | Société Industrielle Limousine d'Application Biologique Dite SILAB (FR) | 2009-02-11 | — | — | EP | disclosed |
| EP-2011517-A1 | Polynucleotide binding complexes comprising sterols and saponin | Nordic Vaccine Technology A/S (DK) | 2009-01-07 | — | — | EP | disclosed |
| EP-2011476-A2 | Moisture-emitting cosmetic and dermatological compounds with enhancers | Henkel AG & Co. KGaA (DE) | 2009-01-07 | — | — | EP | disclosed |
| WO-2008155382-A2 | COSMETIC STICK BASED ON A CONGEALED OIL-IN-WATER DISPERSION/EMULSION HAVING A HYDROGEL FORMER | HENKEL AG & CO. KGAA (DE) | 2008-12-24 | — | — | WO | disclosed |
| WO-2008155391-A2 | COSMETIC STICK BASED ON A CONGEALED OIL-IN-WATER DISPERSION/EMULSION | HENKEL AG & CO. KGAA (DE) | 2008-12-24 | — | — | WO | disclosed |
| EP-2005941-A2 | Cellular rejuvenation compounds | Henkel AG & Co. KGaA (DE) | 2008-12-24 | — | — | EP | disclosed |
| EP-1994923-A2 | Cosmetic and dermatological compositions for dry skin | Henkel AG & Co. KGaA (DE) | 2008-11-26 | — | — | EP | disclosed |
| US-20080268128-A1 | Thickener Composition for Food Products | LUBRIZOL ADVANCED MATERIALS, INC. | 2008-10-30 | — | — | US | disclosed |
| US-20080254015-A1 | Gel Composition of Citrus Complex Carbohydrates Cross-Linked with Cellulose Derivate | AVANTICARE LTD (GB) | 2008-10-16 | — | — | US | disclosed |
| EP-1377320-B1 | POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS | NORDIC VACCINE TECHNOLOGY AS (DK) | 2008-10-01 | — | — | EP | disclosed |
| US-20080206325-A1 | Encapsulated Active Ingredients, Methods of Preparation and Their Use | FIRMENICH SA (CH) | 2008-08-28 | — | — | US | disclosed |
| CN-101252845-A | Encapsulated active ingredients, method of preparation and use thereof | FIRMENICH & CIE (CH) | 2008-08-27 | — | — | CN | disclosed |
| EP-1949887-A2 | Cosmetic formulas for skin smoothing and tautening | Henkel AG & Co. KGaA (DE) | 2008-07-30 | — | — | EP | disclosed |
| US-20080176811-A1 | NOVEL FLAVONE GLYCOSIDE DERIVATIVES FOR USE IN COSMETICS, PHARMACEUTICALS AND NUTRITION | GEERS BERNADETTE | 2008-07-24 | — | — | US | disclosed |
| EP-1943013-A1 | OIL- N-WATER EMULSIONS | Henkel AG & Co. KGaA (DE) | 2008-07-16 | — | — | EP | disclosed |
| EP-1938784-A2 | Pre-treatment agent for protecting the scalp | Henkel AG & Co. KGaA (DE) | 2008-07-02 | — | — | EP | disclosed |
| EP-1938789-A1 | Improvement of the skin friendliness of hyperemizing agents | Henkel AG & Co. KGaA (DE) | 2008-07-02 | — | — | EP | disclosed |
| EP-1938785-A2 | Cosmetic and dermatological oil-in-water emulsions with self-preserving attributes | Henkel AG & Co. KGaA (DE) | 2008-07-02 | — | — | EP | disclosed |
| WO-2008065072-A1 | CLEANSING OR CARE PRODUCT | HENKEL AG & CO. KGAA (DE) | 2008-06-05 | — | — | WO | disclosed |
| EP-1924156-A2 | ENCAPSULATED ACTIVE INGREDIENTS, METHODS OF PREPARATION AND THEIR USE | Firmenich S.A. (CH) | 2008-05-28 | — | — | EP | disclosed |
| WO-2008058943-A2 | LOW-RESIDUE COSMETIC OR DERMATOLOGICAL STICK BASED ON AN OIL-IN-WATER DISPERSION/EMULSION III | HENKEL AG & CO. KGAA (DE) | 2008-05-22 | — | — | WO | disclosed |
| WO-2008057772-A1 | IMPROVED THICKENER COMPOSITION FOR FOOD PRODUCTS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2008-05-15 | — | — | WO | disclosed |
| EP-1913929-A2 | Eudermic W/O emulsions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2008-04-23 | — | — | EP | disclosed |
| EP-1913932-A2 | Eudermic W/O emulsion | Henkel Kommanditgesellschaft auf Aktien (DE) | 2008-04-23 | — | — | EP | disclosed |
| EP-1913930-A2 | Eudermic W/O emulsions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2008-04-23 | — | — | EP | disclosed |
| EP-1913073-A2 | OIL-IN-WATER EMULSIONS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-04-23 | — | — | EP | disclosed |
| EP-1902704-A1 | Cosmetic compositions containing a combination of silicon-elastomers | Henkel KGaA (DE) | 2008-03-26 | — | — | EP | disclosed |
| CN-101151044-A | Composition comprising beta-defensin 2 | HENKEL KGAA (DE) | 2008-03-26 | — | — | CN | disclosed |
| EP-1894994-A1 | Two or more phase face cleansing agent with improved reversible mixing and demixing solution | Henkel KGaA (DE) | 2008-03-05 | — | — | EP | disclosed |
| US-20080050398-A1 | Composition Comprising Beta-Defensin 2 | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2008-02-28 | — | — | US | disclosed |
| EP-1880705-A2 | Brightening and/or colouring composition with improved product sensation | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-01-23 | — | — | EP | disclosed |
| WO-2008003685-A1 | O/W EMULSION | HENKEL AG & CO. KGAA (DE) | 2008-01-10 | — | — | WO | disclosed |
| EP-1863515-A2 | COMPOSITION CONTAINING BETA-DEFENSIN 2 | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-12-12 | — | — | EP | disclosed |
| WO-2007138235-A2 | COSMETIC USE OF A ZOSTERA MARINA EXTRACT | SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE, DITE SILAB (FR) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007135583-A2 | ONE STEP SPRAY-DRYING PROCESS | FIRMENICH SA (CH) | 2007-11-29 | — | — | WO | disclosed |
| US-7294330-B2 | prevent decomposition of steroid ester; inhibit odors | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-11-13 | — | — | US | disclosed |
| WO-2007124889-A2 | QUICK-DRYING COSMETIC EMULSIONS FOR ROLL-ON APPLICATION | HENKEL AG & CO. KGAA (DE) | 2007-11-08 | — | — | WO | disclosed |
| EP-1852102-A2 | Method for manufacturing oil in water emulsions for roll-on applications | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-11-07 | — | — | EP | disclosed |
| EP-1842573-A2 | Brightening and/or colouring agent with improved product sensation | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-10-10 | — | — | EP | disclosed |
| EP-1827095-A2 | COMPOSITIONS AND METHODS FOR ANTI-TRANSPIRATION IN PLANTS | Nonomura, Arthur M. (US) | 2007-09-05 | — | — | EP | disclosed |
| EP-1815843-A2 | Synergistic protein hydrolysate combinations for treating mature skin | Henkel KGaA (DE) | 2007-08-08 | — | — | EP | disclosed |
| EP-1813310-A2 | Cosmetic stick based on an oil in water dispersion/emulsion | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-08-01 | — | — | EP | disclosed |
| EP-1812121-A1 | COSMETIC AND DERMATOLOGICAL PREPARATIONS FOR THE TREATMENT OF MATURE SKIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-08-01 | — | — | EP | disclosed |
| EP-1803435-A2 | Cosmetic sun protection compositions based on lamelliform emulsions | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-07-04 | — | — | EP | disclosed |
| EP-1799311-A2 | COMPOSITIONS WITH INHIBITORS OF THE SYNTHESIS OF PROSTAGLANDIN AND/OR OF LEUKOTRIENE IN CONJUNCTION WITH STIMULATORS OF THE RELEASE OF CUTANEOUS NEUROMEDIATORS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-06-27 | — | — | EP | disclosed |
| EP-1800119-A2 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS CONTAINING ACTIVE SUBSTANCES FOR IMPROVING SENSORY PERCEPTION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-06-27 | — | — | EP | disclosed |
| CN-1980578-A | Encapsulated hydrophilic compounds | FIRMENICH & CIE (CH) | 2007-06-13 | — | — | CN | disclosed |
| WO-2007059822-A1 | COSMETIC COMPOSITIONS CONTAINING ANIONIC SURFACTANT(S) AND IONIC LIQUIDS I | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-05-31 | — | — | WO | disclosed |
| US-20070122398-A1 | Encapsulated hydrophilic compounds | FIRMENICH SA (CH) | 2007-05-31 | — | — | US | disclosed |
| EP-1790330-A2 | Cosmetic and dermatological compositions containing oligopeptides and apple extract | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-05-30 | — | — | EP | disclosed |
| EP-1790328-A1 | Cosmetic compositions comprising anionic detergents and ionic liquids | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-05-30 | — | — | EP | disclosed |
| WO-2007051528-A1 | OIL-ΙN-WATER EMULSIONS | HENKEL AG & CO. KGAA (DE) | 2007-05-10 | — | — | WO | disclosed |
| EP-1776018-A1 | ENCAPSULATED HYDROPHILIC COMPOUNDS | FIRMENICH SA (CH) | 2007-04-25 | — | — | EP | disclosed |
| EP-1776084-A1 | COSMETIC COMPOSITIONS FOR TREATING STRESSED SKIN CONTAINING TAURINE AND LONG-CHAINED FATTY ALCOHOLS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-04-25 | — | — | EP | disclosed |
| EP-1776087-A1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS COMPRISING (2-HYDROXYETHYL)UREA | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-04-25 | — | — | EP | disclosed |
| WO-2007026307-A2 | ENCAPSULATED ACTIVE INGREDIENTS, METHODS OF PREPARATION AND THEIR USE | FIRMENICH SA (CH) | 2007-03-08 | — | — | WO | disclosed |
| WO-2007017196-A2 | OIL-IN-WATER EMULSIONS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-02-15 | — | — | WO | disclosed |
| WO-2007001920-A2 | ENHANCING THE EFFECTIVE CONCENTRATION OF LYSOZYME IN WINE | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 2007-01-04 | — | — | WO | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
| WO-2006103037-A2 | COMPOSITION CONTAINING β-DEFENSIN 2 | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-10-05 | — | — | WO | disclosed |
| EP-1703921-A1 | GEL COMPOSITION OF CITRUS COMPLEX CARBOHYDRATES CROSS-LINKED WITH CELLULOSE DERIVATE | Avanticare Ltd (GB) | 2006-09-27 | — | — | EP | disclosed |
| WO-2006071645-A2 | COMPOSITIONS AND METHODS FOR ANTI-TRANSPIRATION IN PLANTS | NONOMURA ARTHUR M (US) | 2006-07-06 | — | — | WO | disclosed |
| US-20060142158-A1 | Compositions and methods for anti-transpiration in plants | INNOVATION HAMMER, LLC | 2006-06-29 | — | — | US | disclosed |
| EP-1671673-A1 | Pigments containing water-in-siliconoil-emulsion for improving the appearance of the skin | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-06-21 | — | — | EP | disclosed |
| EP-1661601-A2 | Oil in water emulsions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-05-31 | — | — | EP | disclosed |
| EP-1661602-A2 | Oil in water emulsions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-05-31 | — | — | EP | disclosed |
| WO-2006053688-A1 | COSMETIC AND DERMATOLOGICAL PREPARATIONS FOR THE TREATMENT OF MATURE SKIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-05-26 | — | — | WO | disclosed |
| WO-2006042625-A2 | COMPOSITIONS WITH INHIBITORS OF THE SYNTHESIS OF PROSTAGLANDIN AND/OR OF LEUKOTRIENE IN CONJUNCTION WITH STIMULATORS OF THE RELEASE OF CUTANEOUS NEUROMEDIATORS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-04-27 | — | — | WO | disclosed |
| WO-2006042627-A2 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS CONTAINING ACTIVE SUBSTANCES FOR IMPROVING SENSORY PERCEPTION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-04-27 | — | — | WO | disclosed |
| EP-1640041-A2 | Cosmetic and dermatological composition for the treatment of aging or photodamaged skin | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-03-29 | — | — | EP | disclosed |
| EP-1634576-A1 | DNA repair enzymes and oligopeptides containing cosmetic and dermatological compositions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-03-15 | — | — | EP | disclosed |
| WO-2006018149-A1 | COSMETIC COMPOSITIONS FOR TREATING STRESSED SKIN CONTAINING TAURINE AND LONG-CHAINED FATTY ALCOHOLS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-02-23 | — | — | WO | disclosed |
| WO-2006018198-A1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS COMPRISING (2-HYDROXYETHYL)UREA | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-02-23 | — | — | WO | disclosed |
| WO-2006006003-A1 | ENCAPSULATED HYDROPHILIC COMPOUNDS | FIRMENICH SA (CH) | 2006-01-19 | — | — | WO | disclosed |
| US-20050176677-A1 | Cosmetic composition comprising monosaccharides or polysaccharides, uses and treatment methods | DAL FARRA CLAUDE (FR) | 2005-08-11 | — | — | US | disclosed |
| WO-2005067991-A1 | GEL COMPOSITION OF CITRUS COMPLEX CARBOHYDRATES CROSS-LINKED WITH CELLULOSE DERIVATE | AVANTICARE LTD (GB) | 2005-07-28 | — | — | WO | disclosed |
| EP-1141718-B1 | COUPLING OF LIPOPOLYSACCHARIDE-DERIVED CARBOHYDRATES ONTO SOLID SURFACES | EXIQON AS (DK) | 2005-07-20 | — | — | EP | disclosed |
| EP-1530480-A2 | COSMETIC COMPOSITION COMPRISING MONOSACCHARIDES OR POLYSACCHARIDES, USES AND TREATMENT METHODS | Société d'Extraction des Principes Actifs ( Vincience SA) (FR) | 2005-05-18 | — | — | EP | disclosed |
| US-6881549-B2 | Method for introduction of reporter groups into bacterial lipopolysaccharide-derived carbohydrates and the subsequent coupling of such derivatives onto solid surfaces | EXIQON A/S (DK) | 2005-04-19 | — | — | US | disclosed |
| US-20040234466-A1 | Beta-glucuronidase inhibitors for use in deodorants and antiperspirants | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2004-11-25 | — | — | US | disclosed |
| US-20040185057-A1 | Therapeutical vaccination | NORDIC VACCINE TECHNOLOGY A/S (DK) | 2004-09-23 | — | — | US | disclosed |
| EP-1441691-A2 | BETA-GLUCURONIDASE INHIBITORS FOR USE IN DEODORANTS AND ANTIPERSPIRANTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-08-04 | — | — | EP | disclosed |
| EP-1430933-A2 | Cosmetic and pharmaceutical compositions comprising steroid sulfatase inhibitors and their use for the reduction of hair loss | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-23 | — | — | EP | disclosed |
| EP-1430879-A2 | Arylsulfatase inhibitors in deodorants and antiperspirants | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-23 | — | — | EP | disclosed |
| EP-1409009-A1 | THERAPEUTICAL VACCINATION | Nordic Vaccine Technology A/S (DK) | 2004-04-21 | — | — | EP | disclosed |
| EP-1377320-A2 | POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS | Nordic Vaccine Technology A/S (DK) | 2004-01-07 | — | — | EP | disclosed |
| WO-2003092645-A2 | COSMETIC COMPOSITION COMPRISING MONOSACCHARIDES OR POLYSACCHARIDES____________________________________ | SOCIETE D'EXTRACTION DES PRINCIPES ACTIFS (VINCIENCE SA) (FR) | 2003-11-13 | — | — | WO | disclosed |
| US-20030170186-A1 | Novel flavone glycoside derivatives for use in cosmetics, pharmaceuticals and nutrition | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2003-09-11 | — | — | US | disclosed |
| US-20030118635-A1 | Polynucleotide binding complexes comprising sterols and saponins | ISCONOVA AB (SE) | 2003-06-26 | — | — | US | disclosed |
| WO-2003039505-A2 | ss-GLUCURONIDASE INHIBITORS FOR USE IN DEODORANTS AND ANTIPERSPIRANTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-05-15 | — | — | WO | disclosed |
| EP-1274712-A1 | NOVEL FLAVONE GLYCOSIDE DERIVATIVES FOR USE IN COSMETICS, PHARMACEUTICALS AND NUTRITION | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-01-15 | — | — | EP | disclosed |
| WO-2002102407-A1 | THERAPEUTICAL VACCINATION | NORDIC VACCINE TECHNOLOGY A/S (DK) | 2002-12-27 | — | — | WO | disclosed |
| EP-1261310-A1 | COSMETIC AND PHARMACEUTICAL PREPARATIONS FOR TREATING CELLULITE | Henkel Kommanditgesellschaft auf Aktien (DE) | 2002-12-04 | — | — | EP | disclosed |
| EP-1259221-A1 | USE OF FLAVONES OR ISOFLAVONES FOR THE TREATMENT OF CELLULITE | Henkel Kommanditgesellschaft auf Aktien (DE) | 2002-11-27 | — | — | EP | disclosed |
| WO-2002080981-A2 | POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS | NORDIC VACCINE TECHNOLOGY A/S (DK) | 2002-10-17 | — | — | WO | disclosed |
| US-20020128381-A1 | Method for introduction of reporter groups into bacterial lipopolysaccharide-derived carbohydrates and the subsequent coupling of such derivatives onto solid surfaces | EXIQON A/S (DK) | 2002-09-12 | — | — | US | disclosed |
| US-6436653-B1 | DIAGNOSING GRAMNEGATIVE BACTERIA INFECTIONS | EXIQON A/S (DK) | 2002-08-20 | — | — | US | disclosed |
| CN-1335936-A | Method for introducing reporter gene group into bacterial lipopolysaccharide-derived carbohydrate and subsequently coupling the derivative to solid surface | EXIQON AS (DK) | 2002-02-13 | — | — | CN | disclosed |
| WO-2001079241-A1 | GLYCOSIDE ESTERS, THE PRODUCTION AND THE USE THEREOF IN COSMETICS, PHARMACEUTICAL PRODUCTS AND FOODSTUFF OR ANIMAL FEED | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-10-25 | — | — | WO | disclosed |
| WO-2001079245-A1 | NOVEL FLAVONE GLYCOSIDE DERIVATIVES FOR USE IN COSMETICS, PHARMACEUTICALS AND NUTRITION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-10-25 | — | — | WO | disclosed |
| US-20010031735-A1 | Flavonoide esters and their use notably in cosmetics | COLETICA (FR) | 2001-10-18 | — | — | US | disclosed |
| EP-1141718-A1 | COUPLING OF LIPOPOLYSACCHARIDE-DERIVED CARBOHYDRATES ONTO SOLID SURFACES | Exiqon A/S (DK) | 2001-10-10 | — | — | EP | disclosed |
| WO-2001064177-A1 | USE OF FLAVONES OR ISOFLAVONES FOR THE TREATMENT OF CELLULITE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-09-07 | — | — | WO | disclosed |
| WO-2001064167-A1 | COSMETIC AND PHARMACEUTICAL PREPARATIONS FOR TREATING CELLULITE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-09-07 | — | — | WO | disclosed |
| US-6235294-B1 | TOPICAL APPLICATION, OF A COSMETICALLY EFFECTIVE AMOUNT OF HESPERITIN COMPRISING AT LEAST ONE LAUROYL SUBSTITUENT, USES: DERMOPHARMACEUTICAL, PHARMACEUTICAL, DIETETIC OR AGRI-FOODSTUFF COMPOSITIONS | COLETICA (FR) | 2001-05-22 | — | — | US | disclosed |
| US-6103506-A | EXTRACT WITH HYDROLASE ACTIVITY; FOR DESTROYING POLYSACCHARIDE CONSTITUENTS OF THE CELL WALLS | INSTITUTE NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2000-08-15 | — | — | US | disclosed |
| WO-2000036419-A1 | COUPLING OF LIPOPOLYSACCHARIDE-DERIVED CARBOHYDRATES ONTO SOLID SURFACES | EXIQON A/S (DK) | 2000-06-22 | — | — | WO | disclosed |
| CN-1189185-A | Enzymes and microorganisms for the degradation of rhamnogalacturonan II | INST NAT RESEARCH AGRONOMIQUE (FR) | 1998-07-29 | — | — | CN | disclosed |
| EP-0827533-A2 | ENZYME AND MICROORGANISM DEGRADING RHAMNOGALACTURONANE II | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 1998-03-11 | — | — | EP | disclosed |
| WO-1996037604-A2 | ENZYME AND MICROORGANISM DEGRADING RHAMNOGALACTURONANE II | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 1996-11-28 | — | — | WO | disclosed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | disclosed |
| EP-0065123-B1 | HARDLY SOLUBLE SALTS OF AMINOGLYCOSIDE ANTIBIOTICS | MERCK PATENT GmbH (DE) | 1984-07-25 | — | — | EP | disclosed |
| EP-0065123-A1 | Hardly soluble salts of aminoglycoside antibiotics | MERCK PATENT GmbH (DE) | 1982-11-24 | — | — | EP | disclosed |
| EP-0065123-A1 | Hardly soluble salts of aminoglycoside antibiotics | MERCK PATENT GmbH (DE) | 1982-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240408007-A1 | HYDROCOLLOID BLEND COMPOSITIONS FOR TOPICAL APPLICATION | CUTA, DSG1, KRTCAP2 | AKR1B1 3114/4885 |
| US-20240066045-A1 | SEMICARBAZONE-BASED SAPONIN CONJUGATE | SIGLEC7, OSTC, COASY | AKR1B1 351/4885 |
| US-20200101104-A1 | FOOD COMPOSITIONS FOR MANAGING BODY WEIGHT | FABP4, LIPC, PNLIP | AKR1B1 1044/4885 |
| US-20230293562-A1 | THERAPEUTIC COMBINATION OF GALNAC-OLIGONUCLEOTIDE CONJUGATE AND SAPONIN, AND USES THEREOF | ASGR1, HCCS, HAVCR2 | AKR1B1 50/4885 |
| US-20190201437-A1 | FOOD COMPOSITIONS FOR MANAGING BODY WEIGHT | FABP4, LIPC, FABP2 | AKR1B1 913/4885 |
| US-20030170186-A1 | Novel flavone glycoside derivatives for use in cosmetics, pharmaceuticals and nutrition | FOXO1, F12, LPO | AKR1B1 160/4885 |
| US-20220331255-A1 | Solid Dosage Form | SI, CEL, LCT | AKR1B1 2110/4885 |
| US-20010031735-A1 | Flavonoide esters and their use notably in cosmetics | TYR, MITF, CYP2F1 | AKR1B1 219/4885 |
| US-20230277612-A1 | SAPONIN DERIVATIVES FOR USE IN MEDICINE | HAVCR2, HCCS, PYGL | AKR1B1 41/4885 |
| US-20110020226-A1 | PARTICLE STRUCTURES COMPRISING STEROLS AND SAPONINS | LSS, SNRPE, HLA-C | AKR1B1 1374/4885 |
| US-20040234466-A1 | Beta-glucuronidase inhibitors for use in deodorants and antiperspirants | GUSB, PON1, IDUA | AKR1B1 847/4885 |
| US-20200188425-A1 | FOOD AND/OR FEED COMPOSITIONS FOR PREVENTING AND TREATING INFLAMMATORY DISEASES | TNF, FABP2, LCT | AKR1B1 1100/4885 |
| US-20090047226-A1 | Quick-drying cosmetic emulsions for roll-on application | CUTA, UGCG, MGLL | AKR1B1 1991/4885 |
| US-20220249674-A1 | BIOACTIVE SAPONIN LINKED TO A FUNCTIONAL MOIETY | GAA, EEA1, GBA3 | AKR1B1 2401/4885 |
| US-20230293708-A1 | CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF | QTRT1, CD4, BCR | AKR1B1 683/4885 |
| US-20250228762-A1 | COSMETIC COMPOSITION COMPRISING LUTEIN AND A POLYSACCHARIDE | CSGALNACT1, LAGE3, LPL | AKR1B1 3222/4885 |
| US-20030118635-A1 | Polynucleotide binding complexes comprising sterols and saponins | SNRPE, SNRPF, HNRNPAB | AKR1B1 1328/4885 |
| US-20230263897-A1 | CONJUGATE OF GALNAC AND SAPONIN, THERAPEUTIC COMPOSITION COMPRISING SAID CONJUGATE AND A GALNAC-OLIGONUCLEOTIDE CONJUGATE | ASGR1, GYS2, HCCS | AKR1B1 73/4885 |
| US-20250295800-A1 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | CYP46A1, HCCS, DHCR7 | AKR1B1 59/4885 |
| US-20260076992-A1 | COMPOSITIONS AND METHODS FOR TREATING VAGINAL ATROPHY | SHBG, GNRHR, PGF | AKR1B1 4499/4885 |
| US-20250051770-A1 | COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS | TNNC1, MUSK, PYGM | AKR1B1 2899/4885 |
| US-20240307545-A1 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | ASGR1, GYS2, HLA-A | AKR1B1 55/4885 |
| US-20230365617-A1 | SAPONIN DERIVATIVES FOR USE IN MEDICINE | HAVCR2, TTR, PYGL | AKR1B1 39/4885 |
| US-20250082759-A1 | COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND TARGETED SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS | MUSK, TNNC1, PYGM | AKR1B1 2634/4885 |
| US-20230277680-A1 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | CYP46A1, HCCS, DHCR7 | AKR1B1 59/4885 |
| US-20230256111-A1 | COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE | HCCS, CYP46A1, HBB | AKR1B1 56/4885 |
| US-20250250564-A2 | COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS | TNNC1, MUSK, PYGM | AKR1B1 2899/4885 |
| US-20170189444-A1 | POLYMERIC COMPOSITIONS AND RELATED SYSTEMS AND METHODS FOR REGULATING BIOLOGICAL HYDROGELS | ECPAS, HPGDS, COL2A1 | AKR1B1 4752/4885 |
| US-11040060-B2 | Food compositions for managing body weight | FABP4, LIPC, PNLIP | AKR1B1 1044/4885 |
| US-20250057971-A1 | TARGETED SAPONIN-NUCLEIC ACID CONJUGATES FOR TREATMENT OF MUSCLE WASTING DISORDERS | TNNC1, GYS1, PYGM | AKR1B1 2797/4885 |
| US-20240076299-A1 | TUBERCULATIN ANALOGS AS ANTIVIRAL AGENTS | SARS1, TYMP, MAVS | AKR1B1 3716/4885 |
| US-20260049342-A1 | METHODS AND COMPOSITIONS RELATING TO THE SYNTHESIS OF THE QS-7 MOLECULE | QPCT, QTRT1, ACAT2 | AKR1B1 2393/4885 |
| US-20250205361-A1 | TREATMENT REGIMENS FOR THERAPEUTIC EFFECTOR COMPONENTS THAT ACT VIA AN INTRACELLULAR MOLECULAR TARGET | STING1, MTREX, DCLRE1B | AKR1B1 4316/4885 |
| US-11020423-B2 | Food and/or feed compositions for preventing and treating inflammatory diseases | TNF, FABP2, LCT | AKR1B1 1100/4885 |
| US-20100047296-A1 | Low-Residue Cosmetic Or Dermatological Stick Based On An Oil-In-Water Dispersion/Emulsion III | TYR, POLR1C, CUTA | AKR1B1 2129/4885 |
| US-10639323-B2 | Feed compositions for preventing and treating inflammatory diseases | TNF, FABP2, LITAF | AKR1B1 1133/4885 |
| US-20260077055-A1 | COMPOSITIONS OF POLYPLEXES AND SAPONINS | GAA, EEA1, RNASE1 | AKR1B1 1643/4885 |
| US-20080176811-A1 | NOVEL FLAVONE GLYCOSIDE DERIVATIVES FOR USE IN COSMETICS, PHARMACEUTICALS AND NUTRITION | FOXO1, PNN, NQO1 | AKR1B1 309/4885 |
| US-20230248844-A1 | COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE | HCCS, HAVCR2, HMBS | AKR1B1 49/4885 |
| US-20180193375-A1 | FOOD AND/OR FEED COMPOSITIONS FOR PREVENTING AND TREATING INFLAMMATORY DISEASES | TNF, FABP2, LCT | AKR1B1 1100/4885 |
| US-20080050398-A1 | Composition Comprising Beta-Defensin 2 | DLK1, DSG1, DBNL | AKR1B1 4378/4885 |
| US-20240115712-A1 | SEMICARBAZONE-BASED SAPONIN CONJUGATE | OSTC, SIGLEC7, CD44 | AKR1B1 373/4885 |
| US-20230270872-A1 | CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF | QTRT1, CD4, BCR | AKR1B1 683/4885 |
| US-12465571-B2 | Solid dosage form | SI, CEL, LCT | AKR1B1 2110/4885 |
| US-20240115726-A1 | HYDRAZONE-BASED SAPONIN DERIVATIVES | NFATC1, SQLE, HLA-DRB1 | AKR1B1 277/4885 |
| US-20040185057-A1 | Therapeutical vaccination | ICOS, CD69, HAVCR2 | AKR1B1 1858/4885 |
| US-20260000617-A1 | ORAL BIOLOGIC MACROMOLECULE DELIVERY SYSTEM | SI, FABP2, VIP | AKR1B1 2977/4885 |
| US-20230302140-A1 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | CYP46A1, HCCS, DHCR7 | AKR1B1 59/4885 |
| US-20110224159-A1 | BIDESMOSIDIC BETULIN AND BETULINIC ACID DERIVATIVES AND USES THEREOF AS ANTITUMOR AGENTS | BET1, SI, ERG28 | AKR1B1 2863/4885 |
| US-20230357310-A1 | Saponin derivatives with improved therapeutic window | HAVCR2, TTR, PYGL | AKR1B1 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.